December 28, 2024000005697810/4falseQ12025549xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesklic:extend_optionsxbrli:pureklic:segment00000569782024-09-292024-12-280000056978dei:OtherAddressMember2024-09-292024-12-2800000569782025-01-3100000569782024-12-2800000569782024-09-2800000569782023-10-012023-12-300000056978us-gaap:CommonStockMember2024-09-280000056978us-gaap:TreasuryStockCommonMember2024-09-280000056978us-gaap:RetainedEarningsMember2024-09-280000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-280000056978us-gaap:CommonStockMember2024-09-292024-12-280000056978us-gaap:TreasuryStockCommonMember2024-09-292024-12-280000056978us-gaap:RetainedEarningsMember2024-09-292024-12-280000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-292024-12-280000056978us-gaap:CommonStockMember2024-12-280000056978us-gaap:TreasuryStockCommonMember2024-12-280000056978us-gaap:RetainedEarningsMember2024-12-280000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-280000056978us-gaap:CommonStockMember2023-09-300000056978us-gaap:TreasuryStockCommonMember2023-09-300000056978us-gaap:RetainedEarningsMember2023-09-300000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000000569782023-09-300000056978us-gaap:CommonStockMember2023-10-012023-12-300000056978us-gaap:TreasuryStockCommonMember2023-10-012023-12-300000056978us-gaap:RetainedEarningsMember2023-10-012023-12-300000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-300000056978us-gaap:CommonStockMember2023-12-300000056978us-gaap:TreasuryStockCommonMember2023-12-300000056978us-gaap:RetainedEarningsMember2023-12-300000056978us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3000000569782023-12-300000056978klic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-280000056978klic:AftermarketProductsandServicesAPSSegmentMember2024-09-280000056978klic:AllOthersSegmentMember2024-09-280000056978klic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-292024-12-280000056978klic:AftermarketProductsandServicesAPSSegmentMember2024-09-292024-12-280000056978klic:AllOthersSegmentMember2024-09-292024-12-280000056978klic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-12-280000056978klic:AftermarketProductsandServicesAPSSegmentMember2024-12-280000056978klic:AllOthersSegmentMember2024-12-280000056978us-gaap:DevelopedTechnologyRightsMembersrt:MinimumMember2024-12-280000056978us-gaap:DevelopedTechnologyRightsMembersrt:MaximumMember2024-12-280000056978us-gaap:DevelopedTechnologyRightsMember2024-12-280000056978us-gaap:DevelopedTechnologyRightsMember2024-09-280000056978us-gaap:CustomerRelationshipsMembersrt:MinimumMember2024-12-280000056978us-gaap:CustomerRelationshipsMembersrt:MaximumMember2024-12-280000056978us-gaap:CustomerRelationshipsMember2024-12-280000056978us-gaap:CustomerRelationshipsMember2024-09-280000056978us-gaap:TradeNamesMembersrt:MinimumMember2024-12-280000056978us-gaap:TradeNamesMembersrt:MaximumMember2024-12-280000056978us-gaap:TradeNamesMember2024-12-280000056978us-gaap:TradeNamesMember2024-09-280000056978us-gaap:OtherIntangibleAssetsMembersrt:MinimumMember2024-12-280000056978us-gaap:OtherIntangibleAssetsMembersrt:MaximumMember2024-12-280000056978us-gaap:OtherIntangibleAssetsMember2024-12-280000056978us-gaap:OtherIntangibleAssetsMember2024-09-280000056978us-gaap:InProcessResearchAndDevelopmentMember2024-12-280000056978us-gaap:InProcessResearchAndDevelopmentMember2024-09-280000056978us-gaap:MutualFundMember2024-12-280000056978us-gaap:BankTimeDepositsMember2024-12-280000056978us-gaap:MutualFundMember2024-09-280000056978us-gaap:BankTimeDepositsMember2024-09-280000056978us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-292024-12-280000056978us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-12-280000056978us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-280000056978us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-292024-12-280000056978us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-10-012023-12-300000056978srt:MinimumMember2024-12-280000056978srt:MaximumMember2024-12-280000056978klic:CitibankMember2013-11-220000056978klic:CitibankMember2024-12-280000056978klic:MUFGBankLtd.SingaporeBranchMemberklic:FacilityAgreementsMember2019-02-150000056978klic:MUFGBankLtd.SingaporeBranchMemberklic:FacilityAgreementsMember2024-09-292024-12-280000056978klic:MUFGBankLtd.SingaporeBranchMemberklic:FacilityAgreementsMember2024-12-280000056978klic:ProgramAuthorized15August2017Member2017-08-1500000569782018-07-1000000569782019-01-3100000569782020-07-0300000569782022-03-030000056978klic:ProgramAuthorized15August2017Member2024-09-292024-12-280000056978klic:ProgramAuthorized13November2024Member2024-11-130000056978klic:ProgramAuthorized13November2024Member2024-09-292024-12-280000056978klic:ProgramAuthorized13November2024Member2024-12-280000056978us-gaap:AccumulatedTranslationAdjustmentMember2024-09-280000056978us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-280000056978us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-280000056978us-gaap:AccumulatedTranslationAdjustmentMember2024-09-292024-12-280000056978us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-292024-12-280000056978us-gaap:AccumulatedTranslationAdjustmentMember2024-12-280000056978us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-12-280000056978us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-12-280000056978klic:OmnibusIncentivePlanMember2024-12-280000056978klic:RelativeTSRPerformanceShareUnitsMember2024-09-292024-12-280000056978klic:RelativeTSRPerformanceShareUnitsMembersrt:MinimumMember2024-12-280000056978klic:RelativeTSRPerformanceShareUnitsMembersrt:MaximumMember2024-12-280000056978klic:RevenueGrowthPerformanceShareUnitsMember2024-09-292024-12-280000056978klic:RevenueGrowthPerformanceShareUnitsMembersrt:MinimumMember2024-12-280000056978klic:RevenueGrowthPerformanceShareUnitsMembersrt:MaximumMember2024-12-280000056978klic:TimeBasedRestrictedShareUnitsMember2024-09-292024-12-280000056978klic:TimebasedRSUMember2024-09-292024-12-280000056978klic:TimebasedRSUMember2023-10-012023-12-300000056978klic:RelativeTSRPSUMember2024-09-292024-12-280000056978klic:RelativeTSRPSUMember2023-10-012023-12-300000056978klic:SpecialGrowthPSUMember2024-09-292024-12-280000056978klic:SpecialGrowthPSUMember2023-10-012023-12-300000056978us-gaap:CommonStockMember2024-09-292024-12-280000056978us-gaap:CommonStockMember2023-10-012023-12-300000056978us-gaap:CostOfSalesMember2024-09-292024-12-280000056978us-gaap:CostOfSalesMember2023-10-012023-12-300000056978us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-09-292024-12-280000056978us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-10-012023-12-300000056978us-gaap:ResearchAndDevelopmentExpenseMember2024-09-292024-12-280000056978us-gaap:ResearchAndDevelopmentExpenseMember2023-10-012023-12-300000056978klic:BallBondingEquipmentSegmentMember2024-09-292024-12-280000056978klic:BallBondingEquipmentSegmentMember2023-10-012023-12-300000056978klic:WedgeBondingEquipmentSegmentMember2024-09-292024-12-280000056978klic:WedgeBondingEquipmentSegmentMember2023-10-012023-12-300000056978klic:AdvancedSolutionsSegmentMember2024-09-292024-12-280000056978klic:AdvancedSolutionsSegmentMember2023-10-012023-12-300000056978klic:AftermarketProductsandServicesAPSSegmentMember2023-10-012023-12-300000056978klic:AllOthersSegmentMember2023-10-012023-12-300000056978klic:CorporateExpensesMember2024-09-292024-12-280000056978klic:CorporateExpensesMember2023-10-012023-12-300000056978klic:GeneralSemiconductorMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-292024-12-280000056978klic:GeneralSemiconductorMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2023-10-012023-12-300000056978klic:AutomotiveandIndustrialMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-292024-12-280000056978klic:AutomotiveandIndustrialMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2023-10-012023-12-300000056978klic:LEDMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-292024-12-280000056978klic:LEDMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2023-10-012023-12-300000056978klic:MemoryMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2024-09-292024-12-280000056978klic:MemoryMemberklic:AllSegmentsExcludingAftermarketProductsAndServicesAPSMember2023-10-012023-12-300000056978klic:UnfundedCapitalCommitmentsMember2024-12-280000056978klic:FirstTechnologyChinaLtdMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-09-292024-12-280000056978klic:TianshuiHuatianTechnologyCoLtdMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-09-292024-12-280000056978klic:MatfronShanghaiMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-300000056978klic:HuatianTechnologyGroupMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-09-292024-12-280000056978klic:ForehopeElectronicMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-09-292024-12-280000056978klic:ForehopeElectronicMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-10-012023-12-300000056978klic:ProjectWMember2024-11-040000056978klic:ProjectWMember2024-11-042024-11-040000056978klic:KulickeSoffaLiteqB.V.Member2024-10-162024-10-160000056978klic:NelsonWongMember2024-09-292024-12-280000056978klic:NelsonWongMember2024-12-28


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 28, 2024
 
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                  to                    .
 
Commission File No.: 0-121
KULICKE AND SOFFA INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania
23-1498399
(State or other jurisdiction of incorporation)(IRS Employer
 Identification No.)
 
23A Serangoon North Avenue 5, #01-01, Singapore 554369
1005 Virginia Dr., Fort Washington, PA 19034
(Address of principal executive offices and Zip Code)
(215) 784-6000
(Registrant's telephone number, including area code) 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, Without Par ValueKLICThe Nasdaq Global Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐





Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No ☒ 
As of January 31, 2025, there were 53,383,168 shares of the Registrant’s Common Stock, no par value, outstanding.


KULICKE AND SOFFA INDUSTRIES, INC.
FORM 10 – Q
December 28, 2024
 Index
  Page Number
   
PART I - FINANCIAL INFORMATION
   
Item 1.FINANCIAL STATEMENTS (Unaudited) 
   
 
Consolidated Condensed Balance Sheets as of December 28, 2024 and September 28, 2024
   
 
Consolidated Condensed Statements of Operations for the three months ended December 28, 2024 and December 30, 2023
   
Consolidated Condensed Statements of Comprehensive Income for the three months ended December 28, 2024 and December 30, 2023
Consolidated Condensed Statements of Changes in Shareholders’ Equity for the three months ended December 28, 2024 and December 30, 2023
 
Consolidated Condensed Statements of Cash Flows for the three months ended December 28, 2024 and December 30, 2023
   
 Notes to Consolidated Condensed Financial Statements
   
Item 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
   
Item 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
   
Item 4.CONTROLS AND PROCEDURES
   
PART II - OTHER INFORMATION
   
Item 1.LEGAL PROCEEDINGS
Item 1A.RISK FACTORS
   
Item 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Item 3.DEFAULTS UPON SENIOR SECURITIES
Item 4.MINE SAFETY DISCLOSURES
Item 5.OTHER INFORMATION
Item 6.EXHIBITS
   
 SIGNATURES



PART I. - FINANCIAL INFORMATION
Item 1. – FINANCIAL STATEMENTS
KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)
(in thousands)
As of
December 28, 2024September 28, 2024
ASSETS
CURRENT ASSETS
Cash and cash equivalents$278,325 $227,147 
Short-term investments260,000 350,000 
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $49, respectively
247,858 193,909 
Inventories, net185,060 177,736 
Prepaid expenses and other current assets42,646 46,161 
     TOTAL CURRENT ASSETS
1,013,889 994,953 
Property, plant and equipment, net62,467 64,823 
Operating right-of-use assets34,967 35,923 
Goodwill88,411 89,748 
Intangible assets, net22,802 25,239 
Deferred tax assets17,953 17,900 
Equity investments3,385 3,143 
Other assets7,571 8,433 
     TOTAL ASSETS$1,251,445 $1,240,162 
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
  
Accounts payable48,974 58,847 
Operating lease liabilities7,048 7,718 
Accrued expenses and other current liabilities77,073 90,802 
Income taxes payable36,056 26,427 
     TOTAL CURRENT LIABILITIES
169,151 183,794 
Deferred tax liabilities34,657 34,594 
Income taxes payable31,546 31,352 
Operating lease liabilities30,526 33,245 
Other liabilities12,821 13,168 
     TOTAL LIABILITIES$278,701 $296,153 
Commitments and contingent liabilities (Note 15)
SHAREHOLDERS' EQUITY
 
Preferred stock, without par value: Authorized 5,000 shares;
issued - none
$ $ 
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 53,541 and 53,854 shares, respectively
597,901 596,703 
Treasury stock, at cost, 31,823 and 31,510 shares, respectively
(914,241)(881,830)
Retained earnings1,313,213 1,242,558 
Accumulated other comprehensive loss(24,129)(13,422)
     TOTAL SHAREHOLDERS’ EQUITY$972,744 $944,009 
     TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$1,251,445 $1,240,162 

The accompanying notes are an integral part of these consolidated condensed financial statements.
1

KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)
(in thousands, except per share data)
Three months ended
 December 28, 2024December 30, 2023
Net revenue$166,124 $171,189 
Cost of sales79,040 91,293 
Gross profit87,084 79,896 
Selling, general and administrative38,614 41,393 
Research and development37,808 36,810 
Gain relating to cessation of business
(75,987) 
Operating expenses435 78,203 
Income from operations
86,649 1,693 
Interest income6,352 9,899 
Interest expense(27)(22)
Income before income taxes
92,974 11,570 
Provision for income taxes11,332 2,277 
Net income
$81,642 $9,293 
Net income per share:
Basic$1.52 $0.16 
Diluted$1.51 $0.16 
Weighted average shares outstanding:  
Basic53,791 56,650 
Diluted54,212 57,023 

 The accompanying notes are an integral part of these consolidated condensed financial statements.
2

KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(in thousands)
Three months ended
December 28,
2024
December 30,
2023
Net income
$81,642 $9,293 
Other comprehensive (loss)/income:
Foreign currency translation adjustment(8,257)6,280 
Unrecognized actuarial loss/(gain) on pension plan, net of tax
118 (67)
Net (decrease)/increase from derivatives designated as hedging instruments, net of tax
(2,568)1,470 
Total other comprehensive (loss)/income
(10,707)7,683 
Comprehensive income
$70,935 $16,976 
The accompanying notes are an integral part of these consolidated condensed financial statements.











3

KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)
(in thousands)
 Common StockTreasury StockRetained Earnings
Accumulated Other Comprehensive Loss
Shareholders' Equity
Outstanding
Shares
Amount
Balances as of September 28, 202453,854 $596,703 $(881,830)$1,242,558 $(13,422)$944,009 
Issuance of stock for services rendered7 245 70 — — 315 
Repurchase of common stock(793)— (36,879)— — (36,879)
Issuance of shares for equity-based compensation473 (4,873)4,549 — — (324)
Excise tax
— — (151)— — (151)
Equity-based compensation— 5,826 — — — 5,826 
Cash dividend declared ($0.205 per share)
— — — (10,987)— (10,987)
Components of comprehensive income:
Net income— — — 81,642 — 81,642 
Other comprehensive loss
— — — — (10,707)(10,707)
Total comprehensive income/(loss)
— — — 81,642 (10,707)70,935 
Balances as of December 28, 202453,541 $597,901 $(914,241)$1,313,213 $(24,129)$972,744 

 Common StockTreasury StockRetained Earnings Accumulated Other Comprehensive (Loss)/IncomeShareholders' Equity
Outstanding
Shares
Amount
Balances as of September 30, 202356,310 $577,727 $(737,214)$1,355,810 $(21,762)$1,174,561 
Issuance of stock for services rendered7 253 62 — — 315 
Repurchase of common stock(556)— (26,840)— — (26,840)
Issuance of shares for equity-based compensation734 (7,043)7,043 — —  
Equity-based compensation— 7,542 — — — 7,542 
Cash dividend declared ($0.20 per share)
— — — (11,303)— (11,303)
Components of comprehensive income
Net income— — — 9,293 — 9,293 
Other comprehensive income— — — — 7,683 7,683 
Total comprehensive income— — — 9,293 7,683 16,976 
Balances as of December 30, 202356,495 $578,479 $(756,949)$1,353,800 $(14,079)$1,161,251 

 The accompanying notes are an integral part of these consolidated condensed financial statements.

4

KULICKE AND SOFFA INDUSTRIES, INC.
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands)
 Three months ended
 December 28, 2024December 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:  
Net income
$81,642 $9,293 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization5,013 7,985 
Equity-based compensation6,141 7,857 
Adjustment for inventory valuation1,321 2,789 
Deferred taxes10 (678)
(Gain)/loss on disposal of property, plant and equipment
(107)43 
Gain on disposal of a subsidiary
(3,227) 
Unrealized fair value changes on equity investment125 (211)
Unrealized foreign currency translation(2,867)2,565 
Changes in operating assets and liabilities, net of assets and liabilities assumed in businesses combinations:  
Accounts and other receivable(53,938)(25,619)
Inventories(9,050)(22,083)
Prepaid expenses and other current assets1,860 7,547 
Accounts payable, accrued expenses and other current liabilities(15,798)(819)
Income taxes payable9,824 2,396 
Other, net(2,047)1,604 
Net cash provided by/(used in) operating activities
18,902 (7,331)
CASH FLOWS FROM INVESTING ACTIVITIES:  
Disposal of a subsidiary, net of cash disposed of
2,608  
Purchases of property, plant and equipment(10,202)(4,426)
Investment in private equity fund(367)(1,115)
Purchase of short-term investments(115,000)(215,000)
Maturity of short-term investments205,000 160,000 
Net cash provided by/(used in) investing activities
82,039 (60,541)
CASH FLOWS FROM FINANCING ACTIVITIES:  
Payment for finance lease(106)(173)
Repurchase of common stock/treasury stock(37,228)(27,241)
Payments related to tax on vested equity compensation
(324) 
Common stock cash dividends paid(10,794)(10,710)
Net cash used in financing activities(48,452)(38,124)
Effect of exchange rate changes on cash and cash equivalents (1,311)1,254 
Changes in cash and cash equivalents51,178 (104,742)
Cash and cash equivalents at beginning of period227,147 529,402 
Cash and cash equivalents at end of period$278,325 $424,660 
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:
Property, plant and equipment included in accounts payable and accrued expenses$ $893 
CASH PAID FOR:  
Interest$27 $22 
Income taxes, net of refunds$886 $264 
The accompanying notes are an integral part of these consolidated condensed financial statements.
5

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited

NOTE 1. BASIS OF PRESENTATION
These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“K&S,” “we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.
The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “2024 Annual Report”) filed with the Securities and Exchange Commission on November 14, 2024, which includes the Consolidated Balance Sheets as of September 28, 2024 and September 30, 2023, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended September 28, 2024. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.
Fiscal Year    
Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2025 quarters end on December 28, 2024, March 29, 2025, June 28, 2025 and October 4, 2025. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2024 quarters ended on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024.
Nature of Business
The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.

6

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
Use of Estimates
The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory and inventory valuation, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, accrual for employee termination benefits and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.
In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of December 28, 2024. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended December 28, 2024, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods.
Significant Accounting Policies
There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2024 Annual Report.
Recent Accounting Pronouncements
Disclosure Improvements
In October 2023, the Financial Accounting Standards Board (the "FASB") issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU aligns the requirements in the FASB Accounting Standards Codification with the SEC’s regulations. The amendments in the ASU are expected to clarify or improve disclosure and presentation requirements over a variety of Codification Topics. They will also allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC’s regulations. This ASU will become effective for each amendment on the date on which the SEC removes the related disclosure from its regulations. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Segment Reporting
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in the ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. This ASU will be effective for the Company's fiscal year 2025, and interim periods within the fiscal years beginning after the Company’s fiscal year 2026. Early adoption is permitted. The Company will include the required Segment Reporting disclosures within the Notes to Financial Statements with the filing of its Annual Report on Form 10-K for the year ending on October 4, 2025.


7

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
Income Taxes
In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvement to Income Tax Disclosures. The amendments in this update are intended to enhance the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. This ASU will be effective for the Company's fiscal year 2026. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income -Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses. This ASU requires disclosure of certain expenses in the notes to the financial statements. This ASU will be effective for the Company's fiscal 2028 on a prospective basis, with retrospective application permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
8

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)

NOTE 2. BALANCE SHEET COMPONENTS
Components of significant balance sheet accounts as of December 28, 2024 and September 28, 2024 are as follows:
 As of
(in thousands)December 28, 2024September 28, 2024
Inventories, net:  
Raw materials and supplies $110,245 $113,119 
Work in process 43,655 43,023 
Finished goods 58,284 53,378 
 212,184 209,520 
Inventory reserves
(27,124)(31,784)
 $185,060 $177,736 
Property, plant and equipment, net (1):
  
Land$2,182 $2,182 
Buildings and building improvements27,801 23,951 
Leasehold improvements
39,064 44,682 
Data processing equipment and software
37,879 37,917 
Machinery, equipment, furniture and fixtures103,288 105,548 
Construction in progress
6,930 10,060 
 217,144 224,340 
Accumulated depreciation (154,677)(159,517)
 $62,467 $64,823 
Accrued expenses and other current liabilities:  
Accrued customer obligations (2)
$24,822 $31,014 
Wages and benefits
29,110 31,349 
Dividends payable10,987 10,794 
Commissions and professional fees 3,839 4,654 
Accrued leasehold renovations  6,476 
Other8,315 6,515 
 $77,073 $90,802 
(1)Certain balances previously presented as Accumulated Impairment as of September 28, 2024 have been reclassified to conform to the current period presentation. These reclassifications have no impact to the consolidated financial statements in the fiscal period.
(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.
9

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)

NOTE 3. GOODWILL AND INTANGIBLE ASSETS
Goodwill
Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets.
The Company performs an annual impairment test of its goodwill during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.
The Company performed its annual impairment test in the fourth quarter of fiscal 2024 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment in the future.
During the three months ended December 28, 2024, the Company reviewed qualitative factors to ascertain if a “triggering” event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value and concluded that no triggering event had occurred. While we have concluded that a triggering event did not occur during the quarter ended December 28, 2024, the persistent macroeconomic headwinds could, in the future, require changes to assumptions utilized in the determination of the estimated fair values of the reporting units which could result in future goodwill impairment charges. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.
The following table summarizes the changes in the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 14 for further information) as of December 28, 2024 and September 28, 2024:
(in thousands)Wedge Bonding EquipmentAPSAll OthersTotal
Balance at September 28, 2024(1)
$18,280 $26,268 45,200 $89,748 
Other (198)(1,139)$(1,337)
Balance at December 28, 2024$18,280 $26,070 44,061 $88,411 
(1) Cumulative goodwill impairment pertaining to the “All Others” category as of September 28, 2024 was $45.0 million.


10

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
Intangible Assets
Intangible assets with determinable lives are amortized over their estimated useful lives. The Company’s intangible assets consist primarily of developed technology, customer relationships, in-process research and development, and trade and brand names.
The following table reflects net intangible assets as of December 28, 2024 and September 28, 2024: 
 
As of December 28, 2024
As of September 28, 2024
(dollar amounts in thousands)Average estimated
useful lives
(in years)
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Developed technology
6.0 to 15.0
$80,364 $(60,801)$19,563 $83,401 $(61,575)$21,826 
Customer relationships
5.0 to 8.0
$36,554 $(34,912)$1,642 $37,625 $(35,916)$1,709 
Trade and brand name
7.0 to 8.0
$7,095 $(7,095)$ $7,272 $(7,272)$ 
Other intangible assets
1.0 to 8.0
$5,617 $(4,479)$1,138 $5,617 $(4,372)$1,245 
In-process research and developmentN.A$459 $ $459 $459 $ $459 
$130,089 $(107,287)$22,802 $134,374 $(109,135)$25,239 

The following table reflects estimated annual amortization expense related to intangible assets as of December 28, 2024:
 As of
(in thousands)December 28, 2024
Remaining fiscal 2025
$3,705 
Fiscal 2026
4,940 
Fiscal 20274,665 
Fiscal 2028
4,244 
Fiscal 2029
3,255 
Thereafter1,993 
Total amortization expense$22,802 

11

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)

NOTE 4. CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS
Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.
Cash, cash equivalents, and short-term investments consisted of the following as of December 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$27,050 $ $ $27,050 
Cash equivalents:
Mutual Funds (1)
214,247  (3)214,244 
Time deposits (2)
37,031   37,031 
Total cash and cash equivalents$278,328 $ $(3)$278,325 
Short-term investments:
Time deposits (2)
260,000   260,000 
Total short-term investments$260,000 $ $ $260,000 
Total cash, cash equivalents and short-term investments$538,328 $ $(3)$538,325 
(1)Mutual funds held by the Company include Money Market Funds and Ultra-Short Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 28, 2024.
Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$26,800 $ $ $26,800 
Cash equivalents:
Mutual Funds (1)
157,590 89  157,679 
Time deposits (2)
42,668   42,668 
Total cash and cash equivalents$227,058 $89 $ $227,147 
Short-term investments:
Time deposits (2)
350,000   350,000 
Total short-term investments$350,000 $ $ $350,000 
Total cash, cash equivalents and short-term investments$577,058 $89 $ $577,147 
(1)Mutual funds held by the Company include Money Market Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 30, 2023.
12

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
NOTE 5. EQUITY INVESTMENTS
Equity investments consisted of the following as of December 28, 2024 and September 28, 2024:
 As of
(in thousands)December 28, 2024September 28, 2024
Non-marketable equity securities$3,385 $3,143 
Net Asset Value (“NAV”) (Private Equity Fund): Equity investments in affiliated investment funds are valued based on the NAV reported by the investment fund in accordance with ASC Topic 820-10. Investments held by the affiliated investment fund include a diversified portfolio of investments in the global semiconductor industry. The Company receives distributions through the liquidation of the underlying investments by the affiliated investment fund. However, the period of time over which the underlying investments are expected to be liquidated is unknown. Additionally, the Company’s ability to withdraw from the fund is subject to restrictions. The term of the fund will continue until March 18, 2032, unless dissolved earlier or otherwise extended by the General Partner. In accordance with ASC Topic 820-10, this investment is measured at fair value using the NAV per share (or its equivalent) practical expedient and has not been classified in the fair value hierarchy. As of December 28, 2024, the Company has funded $3.8 million into the affiliated investment fund and recognized a cumulative unrealized fair value loss of $0.4 million. The Company has recorded the amount of funded capital that has been called as an equity investment.

NOTE 6. FAIR VALUE MEASUREMENTS
Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 
We measure certain financial assets and liabilities as described in Note 4 and 5 at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three months ended December 28, 2024.
Fair Value Measurements on a Nonrecurring Basis
Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.
Fair Value of Financial Instruments
Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.

NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS
The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.

13

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.
The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of December 28, 2024 and September 28, 2024 were as follows:
As of
December 28, 2024September 28, 2024
(in thousands)Notional Amount
Fair Value Liability
Derivatives(1)
Notional Amount
Fair Value Asset Derivatives(2)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)
$42,486 $(1,047)$46,234 $1,521 
Total derivatives$42,486 $(1,047)$46,234 $1,521 
(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.
(2)The fair value of derivative assets is measured using level 2 fair value inputs and is included in prepaid expenses and other current assets on our Consolidated Condensed Balance Sheets.
(3)Hedged amounts expected to be recognized to income within the next twelve months.
The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three months ended December 28, 2024 and December 30, 2023 were as follows:
Three months ended
(in thousands)December 28, 2024December 30, 2023
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss) / gain recognized in OCI, net of tax(1)
$(2,285)$1,255 
Net gain / (loss) reclassified from accumulated OCI into income, net of tax(2)
$283 $(215)
(1)Net change in the fair value of the effective portion classified in OCI.
(2)Effective portion classified as selling, general and administrative expense.









14

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
NOTE 8. LEASES
We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of December 28, 2024, there were no options to extend the lease which was recognized as a right-of-use (“ROU”) asset, or a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheets as these leases have a lease term of 12 months or less at lease inception.
Operating leases are included in operating ROU assets, current operating lease liabilities and non-current operating lease liabilities, and finance leases are included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheets. As of December 28, 2024 and September 28, 2024, our finance leases are not material.
The following table shows the components of lease expense:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Operating lease expense (1)
$2,348 $2,857 
(1)Operating lease expense includes short-term lease expense and variable lease expenses, which is immaterial for the three months ended December 28, 2024 and December 30, 2023.
The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
 Operating cash outflows from operating leases$2,570 $2,422 
The following table shows the weighted-average lease terms and discount rates for operating leases:
 As of
December 28, 2024September 28, 2024
Operating leases:
Weighted-average remaining lease term (in years):
7.17.3
Weighted-average discount rate:7.1 %7.2 %

15

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
Future lease payments, excluding short-term leases, as of December 28, 2024, are detailed as follows:
As of
(in thousands)December 28, 2024
Remaining fiscal 2025$7,552 
Fiscal 20267,654 
Fiscal 20275,516 
Fiscal 20284,860 
Fiscal 20294,788 
Thereafter17,688 
Total minimum lease payments$48,058 
Less: Interest$10,484 
Present value of lease obligations$37,574 
Less: Current portion$7,048 
Long-term portion of lease obligations$30,526 

NOTE 9. DEBT AND OTHER OBLIGATIONS
Bank Guarantees
On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of December 28, 2024, the outstanding amount under this facility was $4.7 million.
Credit Facilities
On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries' cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of December 28, 2024, there were no outstanding amounts under the Overdraft Facility.








16

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)

NOTE 10. SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS
Share Repurchase Program
On August 15, 2017, the Company’s Board of Directors authorized a program to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019, 2020 and 2022, the Board of Directors increased the share repurchase authorization to $200 million, $300 million, $400 million and $800 million, respectively, and extended its duration through August 1, 2025 (the "Prior Program").
During the three months ended December 28, 2024, the Company repurchased a total of approximately 657.0 thousand shares of common stock under the Prior Program at a cost of approximately $30.3 million. On December 2, 2024, the Company announced that it has completed share repurchases under the Prior Program.
Additionally, and as previously announced on November 13, 2024, the Board of Directors authorized a new share repurchase program to repurchase up to $300 million of the Company's common stock (the "New Program"), with the intention that the New Program initiate upon the completion of the Prior Program.
Contemporaneously, on December 2, 2024, the Company entered into a new written trading plan under Rule 10b5-1 of the Exchange Act, to facilitate repurchases under the New Program. The plan permits the purchase of up to approximately $300 million of the Company’s common stock from December 2, 2024 through December 2, 2029. The New Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the New Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the New Program depend on market conditions as well as corporate and regulatory considerations.
During the three months ended December 28, 2024, the Company repurchased a total of approximately 136.0 thousand shares of common stock under the New Program at a cost of approximately $6.6 million.
The stock repurchases were recorded in the periods the repurchased shares were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.
If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.
As of December 28, 2024, our remaining stock repurchase authorization under the New Program was approximately $293.4 million.
Dividends
On November 13, 2025, the Board of Directors declared a quarterly dividend of $0.205 per share of common stock, representing a $0.005 increase over the last quarterly dividend. Dividends paid during the three months ended December 28, 2024 totaled $10.8 million. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.

17

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
Accumulated Other Comprehensive/Loss
The following table reflects changes in accumulated other comprehensive income/(loss) by component as of December 28, 2024 and September 28, 2024: 
(in thousands)Cumulative Foreign Currency Translation AdjustmentPension Plan Adjustments
Gain/(Loss) on Derivative Instruments
Total
As of September 28, 2024
$(13,261)$(1,682)$1,521 $(13,422)
Other comprehensive income/(loss) before reclassifications
(7,923)118 (2,285)(10,090)
Amount reclassified out of accumulated other comprehensive income/(loss)
(815) (283)(1,098)
Tax effects481   481 
Other comprehensive income/(loss)
(8,257)118 (2,568)(10,707)
As of December 28, 2024
$(21,518)$(1,564)$(1,047)$(24,129)
Equity-Based Compensation
The Company has a stockholder-approved equity-based compensation plan, the 2021 Omnibus Incentive Plan (the “Plan”) from which employees and directors receive grants. As of December 28, 2024, 1.1 million shares of common stock are available for grant to the Company’s employees and directors under the Plan.
Relative Total Shareholder Return Performance Share Units (“Relative TSR PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), if market performance objectives which measure the relative TSR are attained. Relative TSR is calculated based upon the 90-calendar day average price at the end of the performance period of the Company’s stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.
Revenue Growth Performance Share Units (“Growth PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), based on organic revenue growth objectives and relative growth performance against named competitors as set by the Management Development and Compensation Committee (“MDCC”) of the Company’s Board of Directors. Organic revenue growth is calculated by averaging revenue growth (net of revenues from acquisitions) over a performance period, which is generally three years. Revenues from acquisitions will be included in the calculation after four fiscal quarters after acquisition. Any portion of the grant that does not meet the revenue growth objectives and relative growth performance is forfeited. Vesting percentages range from 0% to 200% of awards granted.
In general, Time-based Restricted Share Units (“Time-based RSUs”) awarded to employees vest ratably over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company.
Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 was based upon awards ultimately expected to vest, with forfeiture accounted for when they occur.
18

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(shares in thousands)December 28, 2024December 30, 2023
Time-based RSUs563 499 
Relative TSR PSUs128 231 
Growth PSUs 49 
Common stock7 7 
Equity-based compensation in shares698 786 
The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cost of sales$383 $359 
Selling, general and administrative 3,739 5,680 
Research and development2,019 1,818 
Total equity-based compensation expense$6,141 $7,857 
The following table reflects equity-based compensation expense, by type of award, for the three months ended December 28, 2024 and December 30, 2023:  
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Time-based RSUs$5,156 $4,543 
Relative TSR PSUs1,778 1,560 
Growth PSUs(1,108)1,439 
Common stock315 315 
Total equity-based compensation expense $6,141 $7,857 











19

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
NOTE 11. REVENUE AND CONTRACT BALANCES
The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three months ended December 28, 2024 and December 30, 2023, the service revenue was not material.
The Company reports revenue based on its reportable segments and end markets, which provides information about how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Please refer to Note 14: Segment Information, for disclosure of revenue by segment and end markets.
Contract Balances
As of
(in thousands)December 28, 2024September 28, 2024
Contract liabilities
$12,443 $18,646 
Our contract liabilities are primarily related to payments received in advance of satisfying performance obligations, and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.
Contract liabilities increased as a result of receiving new advanced payments from customers, partially offset by the recognition in revenue of $9.6 million that was included in contract liabilities as of September 28, 2024.

NOTE 12. EARNINGS PER SHARE
Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.
The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands, except per share data)December 28, 2024December 30, 2023
 BasicDilutedBasicDiluted
NUMERATOR:    
Net income
$81,642 $81,642 $9,293 $9,293 
DENOMINATOR:    
Weighted average shares outstanding - Basic53,791 53,791 56,650 56,650 
Dilutive effect of Equity Plans421 373 
Weighted average shares outstanding - Diluted  54,212  57,023 
EPS:    
Net income per share - Basic
$1.52 $1.52 $0.16 $0.16 
Effect of dilutive shares (0.01)  
Net income per share - Diluted
 $1.51  $0.16 
Anti-dilutive shares(1)
125
(1) Represents the Time-based RSUs, Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three months ended December 28, 2024 and December 30, 2023 as the effect would have been anti-dilutive.
20

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
NOTE 13. INCOME TAXES
The following table reflects the provision for income taxes and the effective tax rate for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(dollar amounts in thousands)December 28, 2024December 30, 2023
Provision for income taxes$11,332 $2,277 
Effective tax rate12.2 %19.7 %
For the three months ended December 28, 2024, the increase in provision for income taxes and the decrease in the effective tax rate was primarily due to the reimbursement from Project W cancellation which was recorded as a discrete item in the quarter.
For the three months ended December 28, 2024, the effective tax rate is different than the U.S. federal statutory tax rate primarily due to earnings of foreign subsidiaries subject to tax at different rates than the U.S., tax incentives, tax credits, changes in valuation allowances, the impact of Global Intangible Low-Taxed Income, and the tax impact from the reimbursement of Project W cancellation.

NOTE 14. SEGMENT INFORMATION
Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and assess performance. The Company’s Chief Executive Officer is the CODM. The CODM does not review discrete asset information.
The Company has four reportable segments consisting of: (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). The four reportable segments are disclosed below:
Ball Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment.
Wedge Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of wedge and wedge-related bonding equipment.
Advanced Solutions: Reflects the results of the Company from the design, development, manufacture and sale of certain advanced display, die-attach and thermocompression systems and solutions.
APS: Reflects the results of the Company from the design, development, manufacture and sale of a variety of tools, spares and services for our equipment.
Any other operating segments that have not been aggregated within the reportable segments described above which do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly and die-attach systems and solutions. Results for the “All Others” category and other corporate expenses are included as a reconciling item between the Company’s reportable segments and its consolidated results of operations.

21

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The following table reflects operating information by segment for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Net revenue:  
Ball Bonding Equipment$59,686 $86,270 
Wedge Bonding Equipment32,223 23,459 
Advanced Solutions28,178 11,324 
APS39,386 41,241 
All Others6,651 8,895 
              Net revenue166,124 171,189 
Income from operations:
  
Ball Bonding Equipment13,428 27,714 
Wedge Bonding Equipment6,703 4,294 
Advanced Solutions78,574 (13,435)
APS11,255 12,246 
All Others(3,212)(8,074)
Corporate Expenses(20,099)(21,052)
           Income from operations
$86,649 $1,693 
We have considered: (1) information that is regularly reviewed by our CODM in evaluating financial performance and how to allocate resources; and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served.
The following table reflects net revenue by end markets served for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
General Semiconductor$65,559 $70,948 
Automotive & Industrial 31,175 23,521 
LED 19,279 5,732 
Memory 10,725 29,747 
APS39,386 41,241 
Total revenue$166,124 $171,189 

22

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The following table reflects capital expenditures, depreciation expense and amortization expense for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Capital expenditures:
Ball Bonding Equipment$7 $396 
Wedge Bonding Equipment35 14 
Advanced Solutions78 244 
APS384 425 
All Others148 141 
Corporate Expenses1,459 2,313 
$2,111 $3,533 
Depreciation expense:  
Ball Bonding Equipment$332 $321 
Wedge Bonding Equipment227 284 
Advanced Solutions235 3,047 
APS1,399 1,323 
All Others328 380 
Corporate Expenses1,246 1,283 
$3,767 $6,638 
Amortization expense:
Ball Bonding Equipment$ $ 
Wedge Bonding Equipment  
Advanced Solutions  
APS281 226 
All Others873 1,029 
Corporate Expenses92 92 
$1,246 $1,347 

NOTE 15. COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS
Warranty Expense
The Company’s equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future warranty costs, including product part replacement, freight charges and related labor costs expected to be incurred in correcting manufacturing defects during the warranty period.

23

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The following table reflects the reserve for warranty activity for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Reserve for warranty, beginning of period$9,911 $10,457 
Provision for warranty2,529 2,936 
Utilization of reserve(3,014)(3,226)
Reserve for warranty, end of period$9,426 $10,167 
Other Commitments and Contingencies
The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of December 28, 2024:
  Payments due by fiscal year
(in thousands)Total20252026202720282029Thereafter
Inventory purchase obligation (1)
$137,052 $47,166 $89,886 $ $ $ $ 
(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.
From time to time, the Company is party to or the target of lawsuits, claims, investigations and proceedings, including for personal injury, intellectual property, commercial, contract, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a contingent loss liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. The Company expenses legal costs, including those expected to be incurred in connection with a loss contingency, as incurred.
Unfunded Capital Commitments
As of December 28, 2024, the Company also has an obligation to fund uncalled capital commitments of approximately $6.2 million, as and when required, in relation to its investment in a private equity fund.
Concentrations
The following table reflects significant customer concentrations as a percentage of net revenue for the three months ended December 28, 2024 and December 30, 2023:
Three months ended
December 28, 2024December 30, 2023
First Technology China Ltd.(1)
11.8 %*
Tianshui Huatian Technology Co., Ltd.10.9 %*
Matfron (Shanghai) Semiconductor Technology Co.,Ltd.
*10.6 %
* Represents less than 10% of total net revenue
(1) Distributor of the Company’s products
24

KULICKE AND SOFFA INDUSTRIES, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Unaudited (continued)
The following table reflects significant customer concentrations as a percentage of total accounts receivable as of December 28, 2024 and December 30, 2023:
 As of
December 28, 2024December 30, 2023
Tianshui Huatian Technology Co., Ltd.23.4 %*
Forehope Electronic (Ningbo) Co., Ltd.11.8 %10.7 %
* Represents less than 10% of total accounts receivable

NOTE 16. CESSATION OF BUSINESS
Cancellation of Project
The Company was engaged by one of its customers (the "Customer") to support the Customer with the development and future mass production of certain technologies relating to advanced display (the "Project"), previously referred to as Project W. As previously disclosed in fiscal 2024, in connection with the Customer's strategic review of its business, the Customer informed the Company that it cancelled the Project.
On November 4, 2024, the Company and the Customer entered into a written agreement pursuant to which the Customer had agreed to reimburse the Company for certain costs and expenses that the Company incurred in connection with the Project. Pursuant to the agreement, the Customer agreed to pay $86.2 million to the Company. $15.1 million was included within "Net Revenue" for delivered products. The remaining $71.1 million was included in "Gain relating to cessation of business" in the Consolidated Condensed Statements of Operations, with the corresponding increase to the Accounts and other receivable in our Consolidated Condensed Balance Sheets.
Disposal of a subsidiary
On October 16, 2024, the Company, through one of its subsidiaries, Kulicke and Soffa Holland Holdings B.V., entered into a Share Sale and Purchase Agreement with Onto Innovation Europe B.V. ("Onto") for the sale of 100% of the common shares of Kulicke & Soffa Liteq B.V. ("K&S Liteq") and its related lithography business. The sale was completed on October 18, 2024. Accordingly, the Company has deconsolidated K&S Liteq in the Company’s unaudited condensed consolidated financial statements. The disposal of K&S Liteq did not have a material impact on our consolidated financial statements.
25

Item 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
In addition to historical information, this Quarterly Report contains statements relating to future events or our future results. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor provisions created by statute. Such forward-looking statements include, but are not limited to, statements with respect to our future revenue increasing, continuing or strengthening, or decreasing or weakening; our capital allocation strategies, including any share repurchases; demand for our products, including replacement demand; our research and development efforts; our ability to identify and realize new growth opportunities; our ability to successfully execute our business; our ability to control costs; and our operational flexibility as a result of (among other factors):
our expectations regarding the potential impacts on our business of actual or potential inflationary pressures, interest rate and risk premium adjustments, falling consumer sentiment, or economic recession caused, directly or indirectly, by the ongoing tensions in the Middle East, the prolonged Ukraine/Russia conflict, geopolitical tensions and other macroeconomic factors;
our expectations regarding supply chain disruptions caused, directly or indirectly, by various macroeconomic events, including geopolitical tensions, catastrophic events resulting from climate change or other natural disasters and other factors;
our expectations regarding our effective tax rate and our unrecognized tax benefit;
our ability to operate our business in accordance with our business plan;
our ability to adequately protect our trade secrets and intellectual property rights from misappropriation;
our expectations regarding our success in integrating companies we may acquire with our business, and our ability to continue to acquire or divest companies;
risks inherent in doing business on an international level, including currency risks, regulatory requirements, systems and cybersecurity risks, political risks, evolving trade and export restrictions and other trade-related barriers;
disruptions, breaches or failures in our information technology systems and network infrastructures;
projected growth rates in the overall semiconductor industry, the semiconductor assembly equipment market, and the market for semiconductor packaging materials;
projected demand for our products and services; and
unexpected delays and difficulties in executing against our environmental, climate, diversity and inclusion goals or such other environmental, social and governance (“ESG”) targets and commitments.
Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” “goal” and “believe,” or the negative of or other variations on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this filing. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
Forward-looking statements are based on current expectations and involve risks and uncertainties. Our future results could differ significantly from those expressed or implied by our forward-looking statements. These risks and uncertainties include, without limitation, those described below and in our Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (our “2024 Annual Report”) and our other reports filed from time to time with the Securities and Exchange Commission. This discussion should be read in conjunction with the Consolidated Condensed Financial Statements and Notes included in this Quarterly Report, as well as our audited financial statements included in our 2024 Annual Report.
26

We operate in a rapidly changing and competitive environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. Future events and actual results, performance and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements, which speak only as of the date on which they were made. Except as required by law, we assume no obligation to update or revise any forward-looking statement to reflect actual results or changes in, or additions to, the factors affecting such forward-looking statement. Given those risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictions of actual results.
OVERVIEW
Founded in 1951, Kulicke and Soffa Industries, Inc. (“K&S,” “we,” “us,” “our,” or the “Company”) specializes in developing cutting-edge semiconductor and electronics assembly solutions enabling a smarter and more sustainable future. Our ever-growing range of products and services supports growth and facilitates technology transitions across large-scale markets, such as advanced display, automotive, communications, compute, consumer, data storage, energy storage and industrial.
We design, develop, manufacture and sell capital equipment and consumables and provide services used to assemble semiconductor and electronic devices, such as integrated circuits, power discretes, light-emitting diode (“LEDs”), advanced displays and sensors. We also service, maintain, repair and upgrade our equipment and sell consumable aftermarket solutions and services for our and our peer companies’ equipment. Our customers primarily consist of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers.
Our goal is to be the technology leader and the most competitive supplier in terms of performance, cost and quality in each of our major product lines. Accordingly, we invest in research and engineering projects intended to expand our market access and enhance our leadership position in semiconductor, electronics and display assembly. We also remain focused on enhancing our value to customers through higher productivity systems, more autonomous capabilities and continuous improvement and optimization of our operational costs. Delivering new levels of value to our customers is a critically important goal.
Our Ball Bonding Equipment, Wedge Bonding Equipment and Advanced Solutions reportable segments engage in the design, development, manufacture and sale of ball bonding equipment, wafer level bonding equipment, wedge and wedge-related bonding equipment, certain advanced display, die-attach and thermocompression systems and solutions to IDMs, OSATs, foundry service providers, and other electronics manufacturers and automotive electronics suppliers.
Our APS segment engages in the design, development, manufacture and sale of a variety of tools, spares and services for our equipment. For example, we manufacture capillaries, blades, wedge bonder consumables and other spare parts which complements our equipment and to support a broader range of semiconductor packaging applications. We also provide equipment repair, post-sale support, maintenance and servicing, training services, refurbishment and upgrades for our equipment.
All other operating segments that do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly, and die-attach systems and solutions.

27

Business Environment
The semiconductor business environment is highly volatile and is driven by internal dynamics, both cyclical and seasonal, in addition to macroeconomic forces. Over the long term, semiconductor consumption has historically grown, and is forecasted to continue to grow. This growth is driven, in part, by regular advances in device performance and by price declines that result from improvements in manufacturing technology. In order to exploit these trends, semiconductor manufacturers, both IDMs and OSATs, periodically invest aggressively in the latest generation capital equipment. This buying pattern often leads to periods of excess supply and reduced capital spending — the so-called semiconductor cycle. Within this broad semiconductor cycle there are also, generally weaker, seasonal effects that are specifically tied to annual, end-consumer purchasing patterns. Typically, semiconductor manufacturers prepare for heightened demand by adding or replacing equipment capacity by the end of the September quarter. Occasionally, this results in subsequent reductions in demand during the December quarter. This annual seasonality can be overshadowed by effects of the broader semiconductor cycle. Macroeconomic factors also affect the industry, primarily through their effect on business and consumer demand for electronic devices, as well as other products that have significant electronic content such as automobiles, white goods, and telecommunication equipment. There can be no assurances regarding levels of demand for our products and we believe historic industry-wide volatility will persist.
From time to time, our customers may request that we deliver our products to countries where they own or operate production facilities or to countries where they utilize third-party subcontractors or warehouses as part of their supply chain. For example, customers headquartered in the U.S. may require us to deliver our products to their back-end production facilities in China. Our customer base in the Asia/Pacific region has become more geographically concentrated over time as a result of general economic and industry conditions and trends. Approximately 87.2% and 89.9% of our net revenue for the three months ended December 28, 2024 and December 30, 2023, respectively, were for shipments to customer locations outside of the U.S., primarily in the Asia/Pacific region. Approximately 48.9% and 46.2% of our net revenue for the three months ended December 28, 2024 and December 30, 2023, respectively, were for shipments to customers headquartered in China.
While our customers have generally been impacted by the current global macroeconomic conditions, those with operations in China, an important manufacturing and supply chain hub, have witnessed a faster decline in demand and, accordingly, a faster decline in product shipments, compared to the rest of the world. The shipments to customers headquartered in China are subject to heightened risks and uncertainties related to the respective trade and export control policies of the governments of China and the U.S. Furthermore, there remains a potential risk of conflict and instability in the relationship between Taiwan and China that could disrupt the operations of our customers and/or suppliers in both Taiwan and China and our manufacturing operations in Taiwan and China.
The U.S. and several other countries have levied tariffs on certain goods and have introduced other trade restrictions resulting in substantial uncertainties in the semiconductor, LED, memory and automotive markets.
Our Ball Bonding Equipment, Wedge Bonding Equipment and Advanced Solutions reportable segments, as well as the remaining operating segments in the All Others category, are primarily affected by the industry’s internal cyclical and seasonal dynamics in addition to broader macroeconomic factors that can positively or negatively affect our financial performance. The sales mix of IDM and OSAT customers in any period also impacts financial performance, as changes in this mix can affect our products’ average selling prices and gross margins due to differences in volume purchases and machine configurations required by each customer type.
Our APS reportable segment has historically been less volatile than the other reportable segments. APS sales are more directly tied to semiconductor unit consumption rather than capacity requirements and production capability improvements. 
We continue to position our business to leverage our research and development leadership and innovation and to focus our efforts on mitigating volatility, improving profitability and ensuring longer-term growth. We remain focused on operational excellence, expanding our product offerings through continuous research and development or acquisitions and managing our business efficiently throughout the business cycles. However, our visibility into future demand is generally limited, forecasting is difficult, and we generally experience typical industry seasonality.
To limit potential adverse cyclical, seasonal and macroeconomic effects on our financial position, we have continued our efforts to maintain a strong balance sheet. As of December 28, 2024, our total cash, cash equivalents and short-term investments were $538.3 million, a $38.8 million decrease from the prior fiscal year end. We believe our ability to maintain a strong cash position will allow us to continue to invest in product development, pursue non-organic growth opportunities and return capital to investors through our share repurchase and dividend programs. Please see “Liquidity and Capital Resources” for more information.

28

Key Events in Fiscal 2025 to Date
Cancellation of Project W
The Company was engaged by one of its customers (the "Customer") to support the Customer with the development and future mass production of certain technologies relating to advanced display (the "Project"), previously referred to as Project W. As previously disclosed in fiscal 2024, in connection with the Customer's strategic review of its business, the Customer informed the Company that it cancelled the Project.
On November 4, 2024, the Company and the Customer entered into a written agreement pursuant to which the Customer had agreed to reimburse the Company for certain costs and expenses that the Company incurred in connection with the Project. Pursuant to the agreement, the Customer agreed to pay $86.2 million to the Company. $15.1 million was included within "Net Revenue" for delivered products. The remaining $71.1 million was included in "Gain relating to cessation of business" in the Consolidated Condensed Statements of Operations, with the corresponding increase to the Accounts and other receivable in our Consolidated Condensed Balance Sheets.
Macroeconomic Headwinds
The cost of logistics remains high as a result of macroeconomic conditions, inflation and labor shortages across layers of the supply chain. The Company’s management continues to monitor for signs of any expansion of economic or supply chain disruptions or broader supply chain inflationary and logistical costs resulting either directly or indirectly from the tensions in the Middle East or between Ukraine and Russia.
The ongoing tensions in the Middle East and the prolonged Ukraine/Russia conflict have not had a material impact on our financial condition and operating results in fiscal 2025 to date. We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the ongoing tensions in the Middle East and the prolonged Ukraine/Russia conflict and other macroeconomic factors, for at least the next twelve months from the date of this Quarterly Report. However, this is a highly dynamic situation. As the macroeconomic situation remains highly volatile and the geopolitical situation remains uncertain, there is uncertainty surrounding the operations of our manufacturing locations, our business, our expectations regarding future demand or supply conditions, our near- and long-term liquidity and our financial condition. Consequentially, our operating results could deteriorate.
During fiscal years 2021 and 2022, semiconductor suppliers rapidly increased production output in response to increases in end-consumer demand. Concerns surrounding supply availability spurred defensive inventory purchases, which led to a heightened demand for our products.
The current macroeconomic conditions and declining consumer sentiment during fiscal years 2023 and 2024 have persisted, which continues to exacerbate inventory buildup in the semiconductor industry. Many of our customers who accumulated our products in the past three years continue to reduce their order rates as a result of inventory adjustment.
Due to general inflationary pressures, declining consumer sentiment, and an economic downturn caused, directly or indirectly, by various macroeconomic factors, including the ongoing tensions in the Middle East and the prolonged Ukraine/Russia conflict, the sector continues to experience volatility and disruption. However, we believe that the long-term semiconductor industry macroeconomics have not changed and we anticipate that the industry’s growth projections will normalize.
For a description of the risks to our business arising from or relating to the general macroeconomic conditions, please see Part I, Item 1A, “Risk Factors” of our 2024 Annual Report.
29

RESULTS OF OPERATIONS
The following tables reflect our income from operations for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended  
(dollar amounts in thousands)December 28, 2024December 30, 2023$ Change% Change
Net revenue$166,124 $171,189 $(5,065)(3.0)%
Cost of sales79,040 91,293 (12,253)(13.4)%
Gross profit87,084 79,896 7,188 9.0 %
Selling, general and administrative38,614 41,393 (2,779)(6.7)%
Research and development37,808 36,810 998 2.7 %
Gain relating to cessation of business(75,987)— (75,987)N/A
Operating expenses435 78,203 (77,768)(99.4)%
Income from operations
$86,649 $1,693 $84,956 5,018.1 %
Net Revenue
Our net revenue for the three months ended December 28, 2024 decreased as compared to our net revenue for the three months ended December 30, 2023. The decrease in net revenue is primarily due to lower volume in Ball Bonding Equipment, APS and All Others and partially offset by the higher volume in Wedge Bonding Equipment and Advanced Solutions, as further outlined in the following tables presented immediately below.
The following tables reflect net revenue for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended  
(dollar amounts in thousands)December 28, 2024December 30, 2023$ Change% Change
Net Revenue% of total net revenueNet Revenue% of total net revenue
Ball Bonding Equipment$59,686 35.9 %$86,270 50.4 %$(26,584)(30.8)%
Wedge Bonding Equipment32,223 19.4 %23,459 13.7 %$8,764 37.4 %
Advanced Solutions28,178 17.0 %11,324 6.6 %$16,854 148.8 %
APS39,386 23.7 %41,241 24.1 %(1,855)(4.5)%
All Others6,651 4.0 %8,895 5.2 %(2,244)(25.2)%
Total net revenue$166,124 100.0 %$171,189 100.0 %$(5,065)(3.0)%

30

Ball Bonding Equipment
For the three months ended December 28, 2024, the decrease in Ball Bonding Equipment net revenue as compared to the prior year period was primarily due to lower volume of customer purchases in the general semiconductor and memory end markets as a result of relatively stable factory utilization levels.
Wedge Bonding Equipment
For the three months ended December 28, 2024, the increase in Wedge Bonding Equipment net revenue as compared to the prior year period was primarily due to higher volume of customer purchases primarily in the general semiconductor and automotive markets driven by wider Electric Vehicle adoption in certain regions.
Advanced Solutions
For the three months ended December 28, 2024, the increase in Advanced Solutions net revenue as compared to the prior year period was primarily due to a higher volume of customer purchases in the general semiconductor and LED end markets.
APS
For the three months ended December 28, 2024, the decrease in APS net revenue as compared to the prior year period was due to a lower volume of customer purchases primarily in spares and services.
All Others
For the three months ended December 28, 2024, the decrease in All Others net revenue as compared to the prior year period was primarily due to a lower volume of customer purchases in the general semiconductor end market.
Gross Profit Margin
The following tables reflect gross profit margin as a percentage of net revenue by reportable segments for the three months ended December 28, 2024 and December 30, 2023: 
 Three months endedBasis Point
 December 28, 2024December 30, 2023Change
Ball Bonding Equipment48.1 %47.2 %90 
Wedge Bonding Equipment44.4 %50.4 %(600)
Advanced Solutions77.6 %26.1 %5,150 
APS52.7 %55.2 %(250)
All Others21.9 %17.1 %480 
Total gross profit margin52.4 %46.7 %570 
Ball Bonding Equipment
For the three months ended December 28, 2024, the increase in Ball Bonding Equipment gross profit margin as compared to the prior year period was primarily due to a favorable customer mix, including higher sales to customers where we achieve higher average margins.
Wedge Bonding Equipment
For the three months ended December 28, 2024, the lower Wedge Bonding Equipment gross profit margin as compared to the prior year period was primarily driven by a less favorable product mix, including higher sales of lower margin products and a shift in customer mix, including higher sales to customers where we achieve lower average margins.
Advanced Solutions
For the three months ended December 28, 2024, the increase in Advanced Solutions gross profit margin as compared to the prior year period was primarily due to a favorable product mix which included revenue recognized from delivered products relating to the cancellation of Project W.

31

APS
For the three months ended December 28, 2024, the decrease in APS gross profit margin as compared to the prior year period was primarily driven by lower volume from spares and services, and unfavorable pricing from bonding tools.
All others
For the three months ended December 28, 2024, the higher gross profit margin for the “All Others” category as compared to the prior year period was primarily driven by a provision for excess and obsolete inventory in the prior year period.
Operating Expenses
The following tables reflect operating expenses for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
 (dollar amounts in thousands)December 28, 2024December 30, 2023$ Change% Change
Selling, general & administrative$38,614 $41,393 $(2,779)(6.7)%
Research & development37,808 36,810 998 2.7 %
Gain relating to cessation of business(75,987)— (75,987)N/A
Total$435 $78,203 $(77,768)(99.4)%
Selling, General and Administrative (“SG&A”)
For the three months ended December 28, 2024, the lower SG&A expenses as compared to the prior year period were primarily due to a $4.2 million net favorable variance in foreign exchange. This was partially offset by $0.7 million in severance expenses and $0.3 million in higher staff costs.
Research and Development (“R&D”)
For the three months ended December 28, 2024, the higher R&D expenses as compared to the prior year period were primarily due to $2.9 million higher staff cost related to incentive compensation. This was partially offset by $2.2 million in lower spending on prototype materials.
Gain relating to cessation of business
For the three months ended December 28, 2024, the higher gain relating to cessation of business as compared to the prior year period was primarily due to the $71.1 million reimbursement for certain costs and expenses from Project W cancellation, a $3.2 million gain on the disposal of a subsidiary and a $1.7 million gain from the supplier settlement.


32

Income/(Loss) from Operations
Our income from operations for the three months ended December 28, 2024 increased as compared to our income from operations for the three months ended December 30, 2023. The changes in income from operations for the respective segments are due to the changes in net revenue, gross profit margin and operating expenses as explained in the respective sections above.
The following tables reflect income/(loss) from operations by reportable segments for the three months ended December 28, 2024 and December 30, 2023.
 Three months ended  
(dollar amounts in thousands)December 28, 2024December 30, 2023$ Change% Change
Ball Bonding Equipment$13,428 $27,714 $(14,286)(51.5)%
Wedge Bonding Equipment6,703 4,294 2,409 56.1 %
Advanced Solutions78,574 (13,435)92,009 684.8 %
APS11,255 12,246 (991)(8.1)%
All Others(3,212)(8,074)4,862 60.2 %
Corporate Expenses(20,099)(21,052)953 4.5 %
Total income from operations
$86,649 $1,693 $84,956 5,018.1 %
Interest Income and Expense
The following tables reflect interest income and interest expense for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended  
(dollar amounts in thousands)December 28, 2024December 30, 2023$ Change% Change
Interest income$6,352 $9,899 $(3,547)(35.8)%
Interest expense$(27)$(22)$(5)(22.7)%
Interest income
For the three months ended December 28, 2024, interest income decreased as compared to the prior year period primarily due to a lower average balances of cash, cash equivalents and short-term investments.
Provision for Income Taxes
The following table reflects the provision for income taxes and the effective tax rate for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(dollar amounts in thousands)December 28, 2024December 30, 2023Change
Provision for income taxes$11,332 $2,277 $9,055
Effective tax rate12.2 %19.7 %(7.5)%
For the three months ended December 28, 2024, the increase in provision for income taxes and decrease in the effective tax rate was primarily due to the reimbursement from Project W cancellation which was recorded as a discrete item in the quarter.



33

LIQUIDITY AND CAPITAL RESOURCES
The following table reflects total cash, cash equivalents, and short-term investments as of December 28, 2024 and September 28, 2024:
 As of 
(dollar amounts in thousands)December 28, 2024September 28, 2024$ Change
Cash and cash equivalents$278,325$227,147$51,178 
Short-term investments260,000350,000(90,000)
Total cash, cash equivalents, and short-term investments$538,325$577,147$(38,822)
Percentage of total assets43.0%46.5% 
The following table reflects a summary of the Consolidated Condensed Statements of Cash Flow information for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Net cash provided by/(used in) operating activities
$18,902 $(7,331)
Net cash provided by/(used in) investing activities
82,039 (60,541)
Net cash used in financing activities(48,452)(38,124)
Effect of exchange rate changes on cash and cash equivalents (1,311)1,254 
Changes in cash and cash equivalents$51,178 $(104,742)
Cash and cash equivalents, beginning of period227,147 529,402 
Cash and cash equivalents, end of period$278,325 $424,660 
Three months ended December 28, 2024
The increase in net cash used in operating activities was primarily due to a net income of $81.6 million and non-cash adjustments to net income of $6.4 million, partially offset by a net unfavourable change in operating assets and liabilities of $69.1 million. The net change in operating assets and liabilities was primarily driven by an increase in accounts and other receivable of $53.9 million, an increase in inventories of $9.1 million, and a decrease in accounts payable and accrued expenses and other current liabilities of $15.8 million . This was partially offset by an increase in income tax payable of $9.8 million and a decrease in prepaid expenses and other current assets of $1.9 million.
The increase in accounts and other receivable in the three months ended December 28, 2024 was mainly due to the timing of payments due. The increase in inventories was due to the buildup of long lead time materials to fulfill certain customer purchase orders. The decrease in accounts payable and accrued expenses and other current liabilities was primarily due to lower customer advances, accrued employee compensation and lower material purchases. The increase in income tax payable was primarily due to higher profitability which included the reimbursement from Project W cancellation which was recorded as a discrete item in the quarter.
Net cash provided by investing activities was due to net maturity of short-term investments of $90.0 million and net cash received from the disposal of a subsidiary of $2.6 million, and offset by capital expenditures of $10.2 million and investment in a private equity fund of $0.4 million.
Net cash used in financing activities was primarily due to common stock repurchases of $37.2 million and dividend payments of $10.8 million.




34

Three months ended December 30, 2023
Net cash used in operating activities was primarily due to net income of $9.3 million, non-cash adjustments to net income of $20.4 million and a net unfavorable change in operating assets and liabilities of $37.0 million. The net change in operating assets and liabilities was primarily driven by a increase in accounts and other receivable of $25.6 million, an increase in inventories of $22.1 million and a decrease in accounts payable and accrued expenses and other current liabilities of $0.8 million. This was partially offset by an decrease in prepaid expenses and other current assets of $7.5 million and an increase income tax payable of $2.4 million.
The increase in accounts and other receivable in the three months ended December 30, 2023 was mainly due to the timing of payments due. The increase in inventories was due to the buildup of long lead time materials to fulfill certain customer purchase orders. The decrease in accounts payable and accrued expenses and other current liabilities was primarily due to lower accrued employee compensation that was paid out in the period, partially offset by higher material purchases during the period. The decrease in prepaid expenses was mainly due the transfer of contract assets to net account receivables.
Net cash used in investing activities was due to net purchase of short-term investments of $55.0 million, capital expenditures of $4.4 million and investment in private equity fund of $1.1 million.
Net cash used in financing activities was primarily due to common stock repurchases of $27.2 million and dividend payments of $10.7 million.
Fiscal 2025 Liquidity and Capital Resource Outlook
We expect our aggregate fiscal 2025 capital expenditures to be between approximately $13.0 million and $17.0 million, of which approximately $2.1 million has been incurred through the first quarter. The actual amounts for 2025 will vary depending on market conditions. Expenditures are anticipated to be primarily for research and development projects, enhancements to our manufacturing operations, improvements to our information technology security, implementation of an enterprise resource planning system and leasehold improvements for our facilities. Our ability to make these expenditures will depend, in part, on our future cash flows, which are determined by our future operating performance and, therefore, subject to prevailing macroeconomic conditions, including actual or potential inflationary pressures, supply chain challenges, geopolitical tensions and other factors, some of which are beyond our control.
As of December 28, 2024 and September 28, 2024, approximately $313.8 million and $302.6 million of cash, cash equivalents, and short-term investments, respectively, were held by the Company’s foreign subsidiaries, with a large portion of the cash amounts expected to be available for use in the U.S. without incurring additional U.S. income tax. The decrease is primarily due to the repatriation of cash held by the Company's foreign subsidiaries to the U.S.
The Company’s operations and capital requirements are anticipated to be funded primarily by cash on hand, cash generated from operating activities, and cash from our existing Facility Agreements (as defined below). We believe these sources of cash and liquidity are sufficient to meet our additional liquidity needs for the foreseeable future, including repayment of outstanding balances under the Facility Agreements, as well as payment of dividends, share repurchases and income taxes.
We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the macroeconomic headwinds, for at least the next twelve months and beyond. Our liquidity is affected by many factors, some based on normal operations of our business and others related to macroeconomic conditions including actual or potential inflationary pressures, industry-related uncertainties, and effects arising from the ongoing tensions in the Middle East and the prolonged Ukraine/Russia conflict, which we cannot predict. We also cannot predict economic conditions or industry downturns or the timing, strength or duration of recoveries. We intend to continue to use our cash for working capital needs and for general corporate purposes.
In this unprecedented macroeconomic environment, we may seek, as we believe appropriate, additional debt or equity financing that would provide capital for general corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, semiconductor and semiconductor capital equipment industry conditions, competitive factors, the condition of financial markets and the global economic situation.
35

Share Repurchase Program
On August 15, 2017, the Company’s Board of Directors authorized a program to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019, 2020 and 2022, the Board of Directors increased the share repurchase authorization to $200 million, $300 million, $400 million and $800 million, respectively, and extended its duration through August 1, 2025 (the "Prior Program").
During the three months ended December 28, 2024, the Company repurchased a total of approximately 657.0 thousand shares of common stock under the Prior Program at a cost of approximately $30.3 million. On December 2, 2024, the Company announced that it has completed share repurchases under the Prior Program.
Additionally, and as previously announced on November 13, 2024, the Board of Directors authorized a new share repurchase program to repurchase up to $300 million of the Company's common stock (the "New Program"), with the intention that the New Program initiate upon the completion of the Prior Program.
Contemporaneously, on December 2, 2024, the Company entered into a new written trading plan under Rule 10b5-1 of the Exchange Act, to facilitate repurchases under the New Program. The plan permits the purchase of up to approximately $300 million of the Company’s common stock from December 2, 2024 through December 2, 2029. The New Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the New Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the New Program depend on market conditions as well as corporate and regulatory considerations.
During the three months ended December 28, 2024, the Company repurchased a total of approximately 136.0 thousand shares of common stock under the New Program at a cost of approximately $6.6 million.
The stock repurchases were recorded in the periods the repurchased shares were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.
If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.
As of December 28, 2024, our remaining stock repurchase authorization under the New Program was approximately $293.4 million.
Dividends
On November 13, 2024, the Board of Directors declared a quarterly dividend of $0.205 per share of common stock. Dividends paid during the three months ended December 28, 2024 totaled $10.8 million. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.
Other Obligations and Contingent Payments
In accordance with U.S. GAAP, certain obligations and commitments are not required to be included in the Consolidated Condensed Balance Sheets and Statements of Operations. These obligations and commitments, while entered into in the normal course of business, may have a material impact on our liquidity and are disclosed in the table below.
As of December 28, 2024, the Company had deferred tax liabilities of $34.7 million and unrecognized tax benefits within the income taxes payable for uncertain tax positions of $19.7 million, inclusive of accrued interest on uncertain tax positions of $4.0 million, substantially all of which would affect our effective tax rate in the future, if recognized.


36

It is reasonably possible that the amount of the unrecognized tax benefit with respect to certain unrecognized tax positions will increase or decrease during the next twelve months due to the expected lapse of statutes of limitation and / or settlements of tax examinations. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, we cannot practicably estimate the timing or financial outcomes of these examinations and, therefore, these amounts are excluded from the amounts below.
The following table presents certain payments due by the Company under contractual and statutory obligations with minimum firm commitments as of December 28, 2024:
  Payments due in
(in thousands)TotalLess than 1 year1 - 3 years3 - 5 yearsMore than 5 years
Inventory purchase obligations (1)
$137,052 $47,166 $89,886 $— $— 
U.S. one-time transition tax payable (2)
(reflected on our Consolidated Condensed Balance Sheets)
$28,619 16,808 11,811 — — 
Total$165,671 $63,974 $101,697 $— $— 
(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable and some orders impose varying penalties and charges in the event of cancellation.
(2)Associated with the U.S. one-time transition tax on certain earnings and profits of our foreign subsidiaries in relation to the U.S. Tax Cuts and Job Act of 2017.
Credit facilities
On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”) or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries’ cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company, and breach of a representation or warranty under the Facility Agreements. As of December 28, 2024, there were no outstanding amounts under the Overdraft Facility.
As of December 28, 2024, other than the bank guarantee disclosed in Note 9 of Item 1, we did not have any other off-balance sheet arrangements, such as contingent interests or obligations associated with variable interest entities.









37

Item 3. - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk
Our available-for-sale securities, if applicable, may consist of short-term investments in highly rated debt instruments of the U.S. Government and its agencies, financial institutions, and corporations. We continually monitor our exposure to changes in interest rates and credit ratings of issuers with respect to any available-for-sale securities and target an average life to maturity of less than 18 months. Accordingly, we believe that the effects on us of changes in interest rates and credit ratings of issuers are limited and would not have a material impact on our financial condition or results of operations.
Foreign Currency Risk
Our international operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location’s functional currency. Our international operations are also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. Our U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar. In addition to net monetary remeasurement, we have exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany.
Based on our foreign currency exposure as of December 28, 2024, a 10.0% fluctuation could impact our financial position, results of operations or cash flows by $5.0 million to $6.0 million. Our attempts to hedge against these risks may not be successful and may result in a material adverse impact on our financial results and cash flow.
We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated expenses in the normal course of business and, accordingly, they are not speculative in nature. These instruments generally mature within twelve months. We have foreign exchange forward contracts with a notional amount of $42.5 million outstanding as of December 28, 2024.
38

Item 4. - CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 28, 2024. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of December 28, 2024, our disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms; and (ii) accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding disclosure.
Changes in Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.
In connection with the evaluation by our management, including with the participation of our Chief Executive Officer and Chief Financial Officer, of our internal control over financial reporting, no changes during the three months ended December 28, 2024 were identified to have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

39

PART II. - OTHER INFORMATION 
Item 1. - LEGAL PROCEEDINGS
From time to time, we may be a plaintiff or defendant in cases arising out of our business. We are party to ordinary, routine litigation incidental to our business. We cannot be assured of the results of any pending or future litigation, but we do not believe resolution of any currently pending matters will have a material adverse effect on our business, financial condition or operating results.

Item 1A. - RISK FACTORS
Certain Risks Related to Our Business
There have been no material changes from the risk factors discussed in Part I, Item 1A, “Risk Factors”, of our 2024 Annual Report.

Item 2. - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
The following table summarizes the repurchases of common stock during the three months ended December 28, 2024 (in millions, except number of shares, which are reflected in thousands, and per share amounts):
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(1)
September 29, 2024 to October 26, 2024
313 $44.52 313 $16,309 
October 27, 2024 to November 30, 2024344 $47.33 344 $— 
December 1, 2024 to December 28, 2024
136 $48.89 136 $293,372 
For the three months ended December 28, 2024793 793 
(1)On August 15, 2017, the Company’s Board of Directors authorized the Prior Program, as amended from time to time. Additionally, and as previously announced on November 13, 2024, the Board of Directors authorized the New Program, with the intention that the New Program initiate upon the completion of the Prior Program. Contemporaneously, on December 2, 2024, the Company entered into a new written trading plan under Rule 10b5-1 of the Exchange Act, to facilitate repurchases under the New Program. The plan permits the purchase of up to approximately $300 million of the Company’s common stock from December 2, 2024 through December 2, 2029. The New Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the New Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the New Program depend on market conditions as well as corporate and regulatory considerations.

Item 3. – Defaults Upon Senior Securities.
None.
Item 4. – Mine Safety Disclosures
None.


40

Item 5. – Other Information
Director and Officer Trading Plans and Arrangements
On December 2, 2024, Nelson Wong, Senior Vice President (Global Sales & Supply Chain) of the Company, adopted a Rule 10b5-1 trading arrangement (the "Plan"), pursuant to which a maximum amount of 70,000 common stock of the Company may be sold under the Plan from March 2, 2025 through September 2, 2026. The Plan terminates on the earlier of: (i) September 2, 2026, (ii) the first date on which all trades set forth in the Plan have been executed, or (iii) such date the Plan is otherwise terminated according to its terms.
The above trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act.


41

Item 6. -     Exhibits
  
Exhibit No.Description
3.1
3.2
31.1
  
31.2
  
32.1*
  
32.2*
  
101.INS Inline XBRL Instance Document.
   
101.SCH Inline XBRL Taxonomy Extension Schema Document.
   
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
   
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
   
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
   
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS).
*This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act or the Exchange Act.
 
42

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 KULICKE AND SOFFA INDUSTRIES, INC.
  
Date: February 6, 2025By:/s/ LESTER WONG
Lester Wong
Executive Vice President and Chief Financial Officer
(principal financial officer and principal accounting officer)

43

Exhibit 31.1
 
CERTIFICATION
 
I, Fusen Chen, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
  
d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
  
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
  
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 6, 2025By:/s/ FUSEN CHEN
  Fusen Chen
  President and Chief Executive Officer
  


Exhibit 31.2
 
CERTIFICATION
 
I, Lester Wong, certify that:
  
1.    I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
  
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
  
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: February 6, 2025By:/s/ LESTER WONG
Lester Wong
Executive Vice President and Chief Financial Officer
 


Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Fusen Chen, President and Chief Executive Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1.the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended December 28, 2024 (the “ December 28, 2024 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.the information contained in the December 28, 2024 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.


Date: February 6, 2025By:/s/ FUSEN CHEN
  Fusen Chen
  President and Chief Executive Officer
 



Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Lester Wong, Executive Vice President and Chief Financial Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
 
1. the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended December 28, 2024 (the “December 28, 2024 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2. the information contained in the December 28, 2024 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.

Date: February 6, 2025By:/s/ LESTER WONG
Lester Wong
Executive Vice President and Chief Financial Officer

 


v3.25.0.1
DOCUMENT AND ENTITY INFORMATION - shares
3 Months Ended
Dec. 28, 2024
Jan. 31, 2025
Entity Addresses [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 28, 2024  
Document Transition Report false  
Entity File Number 0-121  
Entity Registrant Name KULICKE AND SOFFA INDUSTRIES, INC.  
Entity Incorporation, State or Country Code PA  
Entity Tax Identification Number 23-1498399  
Entity Address, Address Line One 23A Serangoon North Avenue 5  
Entity Address, Address Line Two #01-01,  
Entity Address, City or Town Singapore  
Entity Address, Country SG  
Entity Address, Postal Zip Code 554369  
City Area Code 215  
Local Phone Number 784-6000  
Title of 12(b) Security Common Stock, Without Par Value  
Trading Symbol KLIC  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   53,383,168
Entity Central Index Key 0000056978  
Current Fiscal Year End Date --10-04  
Amendment Flag false  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Principal Executive Offices    
Entity Addresses [Line Items]    
Entity Address, Address Line One 1005 Virginia Dr.  
Entity Address, City or Town Fort Washington  
Entity Address, Postal Zip Code 19034  
Entity Address, State or Province PA  
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 278,325 $ 227,147
Short-term investments 260,000 350,000
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $49, respectively 247,858 193,909
Inventories, net 185,060 177,736
Prepaid expenses and other current assets 42,646 46,161
TOTAL CURRENT ASSETS 1,013,889 994,953
Property, plant and equipment, net 62,467 64,823
Operating right-of-use assets 34,967 35,923
Goodwill 88,411 89,748
Intangible assets, net 22,802 25,239
Deferred tax assets 17,953 17,900
Equity investments 3,385 3,143
Other assets 7,571 8,433
TOTAL ASSETS 1,251,445 1,240,162
CURRENT LIABILITIES    
Accounts payable 48,974 58,847
Operating lease liabilities 7,048 7,718
Income taxes payable 36,056 26,427
Accrued expenses and other current liabilities 77,073 90,802
TOTAL CURRENT LIABILITIES 169,151 183,794
Deferred tax liabilities 34,657 34,594
Income taxes payable 31,546 31,352
Operating lease liabilities 30,526 33,245
Other liabilities 12,821 13,168
TOTAL LIABILITIES 278,701 296,153
Commitments and contingent liabilities (Note 15)
SHAREHOLDERS' EQUITY    
Preferred stock, without par value: Authorized 5,000 shares; issued - none 0 0
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 53,541 and 53,854 shares, respectively 597,901 596,703
Treasury stock, at cost, 31,823 and 31,510 shares, respectively (914,241) (881,830)
Retained earnings 1,313,213 1,242,558
Accumulated other comprehensive loss (24,129) (13,422)
TOTAL SHAREHOLDERS’ EQUITY 972,744 944,009
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 1,251,445 $ 1,240,162
v3.25.0.1
CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Consolidated Balance Sheets Parenthetical [Abstract]    
Allowance for doubtful accounts and notes receivable $ 49 $ 49
Preferred Stock, Shares Authorized (in shares) 5,000,000 5,000,000
Preferred Stock, Shares Issued (in shares) 0 0
Common Stock, Shares Authorized (in shares) 200,000,000 200,000,000
Common Stock, Shares, Issued (in shares) 85,364,000 85,364,000
Common Stock, Shares, Outstanding (in shares) 53,541,000 53,854,000
Treasury Stock, Common, Shares (in shares) 31,823,000 31,510,000
v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Income Statement [Abstract]    
Net revenue $ 166,124 $ 171,189
Cost of sales 79,040 91,293
Gross profit 87,084 79,896
Selling, general and administrative 38,614 41,393
Research and development 37,808 36,810
Gain relating to cessation of business (75,987) 0
Operating expenses 435 78,203
Income from operations 86,649 1,693
Interest income 6,352 9,899
Interest expense (27) (22)
Income before income taxes 92,974 11,570
Provision for income taxes 11,332 2,277
Net income $ 81,642 $ 9,293
Net income per share:    
Basic (in dollars per share) $ 1.52 $ 0.16
Diluted (in dollars per share) $ 1.51 $ 0.16
Weighted average shares outstanding:    
Basic (in shares) 53,791 56,650
Diluted (in shares) 54,212 57,023
v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 81,642 $ 9,293
Other comprehensive (loss)/income:    
Foreign currency translation adjustment (8,257) 6,280
Unrecognized actuarial loss/(gain) on pension plan, net of tax 118 (67)
Net (decrease)/increase from derivatives designated as hedging instruments, net of tax (2,568) 1,470
Other comprehensive loss (10,707) 7,683
Comprehensive income $ 70,935 $ 16,976
v3.25.0.1
CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (shares) at Sep. 30, 2023   56,310      
Beginning balance at Sep. 30, 2023 $ 1,174,561 $ 577,727 $ (737,214) $ 1,355,810 $ (21,762)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of stock for services rendered (shares)   7      
Issuance of stock for services rendered 315 $ 253 62    
Repurchase of common stock (shares)   (556)      
Repurchase of common stock (26,840)   (26,840)    
Issuance of shares for equity based compensation (shares)   734      
Issuance of shares for equity-based compensation 0 $ (7,043) 7,043    
Equity-based compensation 7,542 $ 7,542      
Cash dividend declared ($0.205 per share) (11,303)     (11,303)  
Net income 9,293     9,293  
Other comprehensive loss 7,683       7,683
Comprehensive income 16,976     9,293 7,683
Ending balance (shares) at Dec. 30, 2023   56,495      
Ending balance at Dec. 30, 2023 $ 1,161,251 $ 578,479 (756,949) 1,353,800 (14,079)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cash dividends declared (in dollars per share) $ 0.20        
Beginning balance (shares) at Sep. 28, 2024   53,854      
Beginning balance at Sep. 28, 2024 $ 944,009 $ 596,703 (881,830) 1,242,558 (13,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of stock for services rendered (shares)   7      
Issuance of stock for services rendered 315 $ 245 70    
Repurchase of common stock (shares)   (793)      
Repurchase of common stock (36,879)   (36,879)    
Issuance of shares for equity based compensation (shares)   473      
Issuance of shares for equity-based compensation (324) $ (4,873) 4,549    
Excise tax (151)   (151)    
Equity-based compensation 5,826 $ 5,826      
Cash dividend declared ($0.205 per share) (10,987)     (10,987)  
Net income 81,642     81,642  
Other comprehensive loss (10,707)       (10,707)
Comprehensive income 70,935     81,642 (10,707)
Ending balance (shares) at Dec. 28, 2024   53,541      
Ending balance at Dec. 28, 2024 $ 972,744 $ 597,901 $ (914,241) $ 1,313,213 $ (24,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cash dividends declared (in dollars per share) $ 0.205        
v3.25.0.1
CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Statement of Stockholders' Equity [Abstract]    
Cash dividends declared (in dollars per share) $ 0.205 $ 0.20
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 81,642 $ 9,293
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,013 7,985
Equity-based compensation 6,141 7,857
Adjustment for inventory valuation 1,321 2,789
Deferred taxes 10 (678)
(Gain)/loss on disposal of property, plant and equipment (107) 43
Gain on disposal of a subsidiary (3,227) 0
Unrealized fair value changes on equity investment 125 (211)
Unrealized foreign currency translation (2,867) 2,565
Changes in operating assets and liabilities, net of assets and liabilities assumed in businesses combinations:    
Accounts and other receivable (53,938) (25,619)
Inventories (9,050) (22,083)
Prepaid expenses and other current assets 1,860 7,547
Accounts payable, accrued expenses and other current liabilities (15,798) (819)
Income taxes payable 9,824 2,396
Other, net (2,047) 1,604
Net cash provided by/(used in) operating activities 18,902 (7,331)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Disposal of a subsidiary, net of cash disposed of 2,608 0
Purchases of property, plant and equipment (10,202) (4,426)
Investment in private equity fund (367) (1,115)
Purchase of short-term investments (115,000) (215,000)
Maturity of short-term investments 205,000 160,000
Net cash provided by/(used in) investing activities 82,039 (60,541)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payment for finance lease (106) (173)
Repurchase of common stock/treasury stock (37,228) (27,241)
Payments related to tax on vested equity compensation (324) 0
Common stock cash dividends paid (10,794) (10,710)
Net cash used in financing activities (48,452) (38,124)
Effect of exchange rate changes on cash and cash equivalents (1,311) 1,254
Changes in cash and cash equivalents 51,178 (104,742)
Cash and cash equivalents at beginning of period 227,147 529,402
Cash and cash equivalents at end of period 278,325 424,660
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:    
Property, plant and equipment included in accounts payable and accrued expenses 0 893
CASH PAID FOR:    
Interest 27 22
Income taxes, net of refunds $ 886 $ 264
v3.25.0.1
BASIS OF PRESENTATION
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF PRESENTATION 1. BASIS OF PRESENTATION
These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“K&S,” “we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.
The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “2024 Annual Report”) filed with the Securities and Exchange Commission on November 14, 2024, which includes the Consolidated Balance Sheets as of September 28, 2024 and September 30, 2023, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended September 28, 2024. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.
Fiscal Year    
Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2025 quarters end on December 28, 2024, March 29, 2025, June 28, 2025 and October 4, 2025. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2024 quarters ended on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024.
Nature of Business
The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.
Use of Estimates
The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory and inventory valuation, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, accrual for employee termination benefits and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.
In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of December 28, 2024. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended December 28, 2024, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods.
Significant Accounting Policies
There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2024 Annual Report.
Recent Accounting Pronouncements
Disclosure Improvements
In October 2023, the Financial Accounting Standards Board (the "FASB") issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU aligns the requirements in the FASB Accounting Standards Codification with the SEC’s regulations. The amendments in the ASU are expected to clarify or improve disclosure and presentation requirements over a variety of Codification Topics. They will also allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC’s regulations. This ASU will become effective for each amendment on the date on which the SEC removes the related disclosure from its regulations. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Segment Reporting
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in the ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. This ASU will be effective for the Company's fiscal year 2025, and interim periods within the fiscal years beginning after the Company’s fiscal year 2026. Early adoption is permitted. The Company will include the required Segment Reporting disclosures within the Notes to Financial Statements with the filing of its Annual Report on Form 10-K for the year ending on October 4, 2025.
Income Taxes
In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvement to Income Tax Disclosures. The amendments in this update are intended to enhance the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. This ASU will be effective for the Company's fiscal year 2026. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income -Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses. This ASU requires disclosure of certain expenses in the notes to the financial statements. This ASU will be effective for the Company's fiscal 2028 on a prospective basis, with retrospective application permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
v3.25.0.1
BALANCE SHEET COMPONENTS
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BALANCE SHEET COMPONENTS 2. BALANCE SHEET COMPONENTS
Components of significant balance sheet accounts as of December 28, 2024 and September 28, 2024 are as follows:
 As of
(in thousands)December 28, 2024September 28, 2024
Inventories, net:  
Raw materials and supplies $110,245 $113,119 
Work in process 43,655 43,023 
Finished goods 58,284 53,378 
 212,184 209,520 
Inventory reserves
(27,124)(31,784)
 $185,060 $177,736 
Property, plant and equipment, net (1):
  
Land$2,182 $2,182 
Buildings and building improvements27,801 23,951 
Leasehold improvements
39,064 44,682 
Data processing equipment and software
37,879 37,917 
Machinery, equipment, furniture and fixtures103,288 105,548 
Construction in progress
6,930 10,060 
 217,144 224,340 
Accumulated depreciation (154,677)(159,517)
 $62,467 $64,823 
Accrued expenses and other current liabilities:  
Accrued customer obligations (2)
$24,822 $31,014 
Wages and benefits
29,110 31,349 
Dividends payable10,987 10,794 
Commissions and professional fees 3,839 4,654 
Accrued leasehold renovations — 6,476 
Other8,315 6,515 
 $77,073 $90,802 
(1)Certain balances previously presented as Accumulated Impairment as of September 28, 2024 have been reclassified to conform to the current period presentation. These reclassifications have no impact to the consolidated financial statements in the fiscal period.
(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.
v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS
3 Months Ended
Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS 3. GOODWILL AND INTANGIBLE ASSETS
Goodwill
Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets.
The Company performs an annual impairment test of its goodwill during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.
The Company performed its annual impairment test in the fourth quarter of fiscal 2024 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment in the future.
During the three months ended December 28, 2024, the Company reviewed qualitative factors to ascertain if a “triggering” event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value and concluded that no triggering event had occurred. While we have concluded that a triggering event did not occur during the quarter ended December 28, 2024, the persistent macroeconomic headwinds could, in the future, require changes to assumptions utilized in the determination of the estimated fair values of the reporting units which could result in future goodwill impairment charges. Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.
The following table summarizes the changes in the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 14 for further information) as of December 28, 2024 and September 28, 2024:
(in thousands)Wedge Bonding EquipmentAPSAll OthersTotal
Balance at September 28, 2024(1)
$18,280 $26,268 45,200 $89,748 
Other— (198)(1,139)$(1,337)
Balance at December 28, 2024$18,280 $26,070 44,061 $88,411 
(1) Cumulative goodwill impairment pertaining to the “All Others” category as of September 28, 2024 was $45.0 million.
Intangible Assets
Intangible assets with determinable lives are amortized over their estimated useful lives. The Company’s intangible assets consist primarily of developed technology, customer relationships, in-process research and development, and trade and brand names.
The following table reflects net intangible assets as of December 28, 2024 and September 28, 2024: 
 
As of December 28, 2024
As of September 28, 2024
(dollar amounts in thousands)Average estimated
useful lives
(in years)
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Developed technology
6.0 to 15.0
$80,364 $(60,801)$19,563 $83,401 $(61,575)$21,826 
Customer relationships
5.0 to 8.0
$36,554 $(34,912)$1,642 $37,625 $(35,916)$1,709 
Trade and brand name
7.0 to 8.0
$7,095 $(7,095)$— $7,272 $(7,272)$— 
Other intangible assets
1.0 to 8.0
$5,617 $(4,479)$1,138 $5,617 $(4,372)$1,245 
In-process research and developmentN.A$459 $— $459 $459 $— $459 
$130,089 $(107,287)$22,802 $134,374 $(109,135)$25,239 

The following table reflects estimated annual amortization expense related to intangible assets as of December 28, 2024:
 As of
(in thousands)December 28, 2024
Remaining fiscal 2025
$3,705 
Fiscal 2026
4,940 
Fiscal 20274,665 
Fiscal 2028
4,244 
Fiscal 2029
3,255 
Thereafter1,993 
Total amortization expense$22,802 
v3.25.0.1
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS
3 Months Ended
Dec. 28, 2024
Cash and Cash Equivalents [Abstract]  
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS 4. CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS
Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.
Cash, cash equivalents, and short-term investments consisted of the following as of December 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$27,050 $— $— $27,050 
Cash equivalents:
Mutual Funds (1)
214,247 — (3)214,244 
Time deposits (2)
37,031 — — 37,031 
Total cash and cash equivalents$278,328 $— $(3)$278,325 
Short-term investments:
Time deposits (2)
260,000 — — 260,000 
Total short-term investments$260,000 $— $— $260,000 
Total cash, cash equivalents and short-term investments$538,328 $— $(3)$538,325 
(1)Mutual funds held by the Company include Money Market Funds and Ultra-Short Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 28, 2024.
Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$26,800 $— $— $26,800 
Cash equivalents:
Mutual Funds (1)
157,590 89 — 157,679 
Time deposits (2)
42,668 — — 42,668 
Total cash and cash equivalents$227,058 $89 $— $227,147 
Short-term investments:
Time deposits (2)
350,000 — — 350,000 
Total short-term investments$350,000 $— $— $350,000 
Total cash, cash equivalents and short-term investments$577,058 $89 $— $577,147 
(1)Mutual funds held by the Company include Money Market Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 30, 2023.
v3.25.0.1
EQUITY INVESTMENTS
3 Months Ended
Dec. 28, 2024
Equity Method Investments [Abstract]  
EQUITY INVESTMENTS 5. EQUITY INVESTMENTS
Equity investments consisted of the following as of December 28, 2024 and September 28, 2024:
 As of
(in thousands)December 28, 2024September 28, 2024
Non-marketable equity securities$3,385 $3,143 
Net Asset Value (“NAV”) (Private Equity Fund): Equity investments in affiliated investment funds are valued based on the NAV reported by the investment fund in accordance with ASC Topic 820-10. Investments held by the affiliated investment fund include a diversified portfolio of investments in the global semiconductor industry. The Company receives distributions through the liquidation of the underlying investments by the affiliated investment fund. However, the period of time over which the underlying investments are expected to be liquidated is unknown. Additionally, the Company’s ability to withdraw from the fund is subject to restrictions. The term of the fund will continue until March 18, 2032, unless dissolved earlier or otherwise extended by the General Partner. In accordance with ASC Topic 820-10, this investment is measured at fair value using the NAV per share (or its equivalent) practical expedient and has not been classified in the fair value hierarchy. As of December 28, 2024, the Company has funded $3.8 million into the affiliated investment fund and recognized a cumulative unrealized fair value loss of $0.4 million. The Company has recorded the amount of funded capital that has been called as an equity investment.
v3.25.0.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Dec. 28, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASURMENTS 6. FAIR VALUE MEASUREMENTS
Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 
We measure certain financial assets and liabilities as described in Note 4 and 5 at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three months ended December 28, 2024.
Fair Value Measurements on a Nonrecurring Basis
Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.
Fair Value of Financial Instruments
Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.
v3.25.0.1
DERIVATIVES FINANCIAL INSTRUMENTS (Notes)
3 Months Ended
Dec. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVES FINANCIAL INSTRUMENTS 7. DERIVATIVE FINANCIAL INSTRUMENTS
The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.
The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.
The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of December 28, 2024 and September 28, 2024 were as follows:
As of
December 28, 2024September 28, 2024
(in thousands)Notional Amount
Fair Value Liability
Derivatives(1)
Notional Amount
Fair Value Asset Derivatives(2)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)
$42,486 $(1,047)$46,234 $1,521 
Total derivatives$42,486 $(1,047)$46,234 $1,521 
(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.
(2)The fair value of derivative assets is measured using level 2 fair value inputs and is included in prepaid expenses and other current assets on our Consolidated Condensed Balance Sheets.
(3)Hedged amounts expected to be recognized to income within the next twelve months.
The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three months ended December 28, 2024 and December 30, 2023 were as follows:
Three months ended
(in thousands)December 28, 2024December 30, 2023
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss) / gain recognized in OCI, net of tax(1)
$(2,285)$1,255 
Net gain / (loss) reclassified from accumulated OCI into income, net of tax(2)
$283 $(215)
(1)Net change in the fair value of the effective portion classified in OCI.
(2)Effective portion classified as selling, general and administrative expense.
v3.25.0.1
LEASES
3 Months Ended
Dec. 28, 2024
Leases [Abstract]  
Leases 8. LEASES
We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of December 28, 2024, there were no options to extend the lease which was recognized as a right-of-use (“ROU”) asset, or a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheets as these leases have a lease term of 12 months or less at lease inception.
Operating leases are included in operating ROU assets, current operating lease liabilities and non-current operating lease liabilities, and finance leases are included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheets. As of December 28, 2024 and September 28, 2024, our finance leases are not material.
The following table shows the components of lease expense:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Operating lease expense (1)
$2,348 $2,857 
(1)Operating lease expense includes short-term lease expense and variable lease expenses, which is immaterial for the three months ended December 28, 2024 and December 30, 2023.
The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
 Operating cash outflows from operating leases$2,570 $2,422 
The following table shows the weighted-average lease terms and discount rates for operating leases:
 As of
December 28, 2024September 28, 2024
Operating leases:
Weighted-average remaining lease term (in years):
7.17.3
Weighted-average discount rate:7.1 %7.2 %
Future lease payments, excluding short-term leases, as of December 28, 2024, are detailed as follows:
As of
(in thousands)December 28, 2024
Remaining fiscal 2025$7,552 
Fiscal 20267,654 
Fiscal 20275,516 
Fiscal 20284,860 
Fiscal 20294,788 
Thereafter17,688 
Total minimum lease payments$48,058 
Less: Interest$10,484 
Present value of lease obligations$37,574 
Less: Current portion$7,048 
Long-term portion of lease obligations$30,526 
v3.25.0.1
DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Notes)
3 Months Ended
Dec. 28, 2024
Debt Disclosure [Abstract]  
Debt and Other Obligations 9. DEBT AND OTHER OBLIGATIONS
Bank Guarantees
On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of December 28, 2024, the outstanding amount under this facility was $4.7 million.
Credit Facilities
On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries' cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of December 28, 2024, there were no outstanding amounts under the Overdraft Facility.
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS
3 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS 10. SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS
Share Repurchase Program
On August 15, 2017, the Company’s Board of Directors authorized a program to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019, 2020 and 2022, the Board of Directors increased the share repurchase authorization to $200 million, $300 million, $400 million and $800 million, respectively, and extended its duration through August 1, 2025 (the "Prior Program").
During the three months ended December 28, 2024, the Company repurchased a total of approximately 657.0 thousand shares of common stock under the Prior Program at a cost of approximately $30.3 million. On December 2, 2024, the Company announced that it has completed share repurchases under the Prior Program.
Additionally, and as previously announced on November 13, 2024, the Board of Directors authorized a new share repurchase program to repurchase up to $300 million of the Company's common stock (the "New Program"), with the intention that the New Program initiate upon the completion of the Prior Program.
Contemporaneously, on December 2, 2024, the Company entered into a new written trading plan under Rule 10b5-1 of the Exchange Act, to facilitate repurchases under the New Program. The plan permits the purchase of up to approximately $300 million of the Company’s common stock from December 2, 2024 through December 2, 2029. The New Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the New Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the New Program depend on market conditions as well as corporate and regulatory considerations.
During the three months ended December 28, 2024, the Company repurchased a total of approximately 136.0 thousand shares of common stock under the New Program at a cost of approximately $6.6 million.
The stock repurchases were recorded in the periods the repurchased shares were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.
If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.
As of December 28, 2024, our remaining stock repurchase authorization under the New Program was approximately $293.4 million.
Dividends
On November 13, 2025, the Board of Directors declared a quarterly dividend of $0.205 per share of common stock, representing a $0.005 increase over the last quarterly dividend. Dividends paid during the three months ended December 28, 2024 totaled $10.8 million. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.
Accumulated Other Comprehensive/Loss
The following table reflects changes in accumulated other comprehensive income/(loss) by component as of December 28, 2024 and September 28, 2024: 
(in thousands)Cumulative Foreign Currency Translation AdjustmentPension Plan Adjustments
Gain/(Loss) on Derivative Instruments
Total
As of September 28, 2024
$(13,261)$(1,682)$1,521 $(13,422)
Other comprehensive income/(loss) before reclassifications
(7,923)118 (2,285)(10,090)
Amount reclassified out of accumulated other comprehensive income/(loss)
(815)— (283)(1,098)
Tax effects481 — — 481 
Other comprehensive income/(loss)
(8,257)118 (2,568)(10,707)
As of December 28, 2024
$(21,518)$(1,564)$(1,047)$(24,129)
Equity-Based Compensation
The Company has a stockholder-approved equity-based compensation plan, the 2021 Omnibus Incentive Plan (the “Plan”) from which employees and directors receive grants. As of December 28, 2024, 1.1 million shares of common stock are available for grant to the Company’s employees and directors under the Plan.
Relative Total Shareholder Return Performance Share Units (“Relative TSR PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), if market performance objectives which measure the relative TSR are attained. Relative TSR is calculated based upon the 90-calendar day average price at the end of the performance period of the Company’s stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.
Revenue Growth Performance Share Units (“Growth PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), based on organic revenue growth objectives and relative growth performance against named competitors as set by the Management Development and Compensation Committee (“MDCC”) of the Company’s Board of Directors. Organic revenue growth is calculated by averaging revenue growth (net of revenues from acquisitions) over a performance period, which is generally three years. Revenues from acquisitions will be included in the calculation after four fiscal quarters after acquisition. Any portion of the grant that does not meet the revenue growth objectives and relative growth performance is forfeited. Vesting percentages range from 0% to 200% of awards granted.
In general, Time-based Restricted Share Units (“Time-based RSUs”) awarded to employees vest ratably over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company.
Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three months ended December 28, 2024 and December 30, 2023 was based upon awards ultimately expected to vest, with forfeiture accounted for when they occur.
The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(shares in thousands)December 28, 2024December 30, 2023
Time-based RSUs563 499 
Relative TSR PSUs128 231 
Growth PSUs— 49 
Common stock
Equity-based compensation in shares698 786 
The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cost of sales$383 $359 
Selling, general and administrative 3,739 5,680 
Research and development2,019 1,818 
Total equity-based compensation expense$6,141 $7,857 
The following table reflects equity-based compensation expense, by type of award, for the three months ended December 28, 2024 and December 30, 2023:  
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Time-based RSUs$5,156 $4,543 
Relative TSR PSUs1,778 1,560 
Growth PSUs(1,108)1,439 
Common stock315 315 
Total equity-based compensation expense $6,141 $7,857 
v3.25.0.1
REVENUE AND CONTRACT BALANCES
3 Months Ended
Dec. 28, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE AND CONTRACT BALANCES 11. REVENUE AND CONTRACT BALANCES
The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three months ended December 28, 2024 and December 30, 2023, the service revenue was not material.
The Company reports revenue based on its reportable segments and end markets, which provides information about how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Please refer to Note 14: Segment Information, for disclosure of revenue by segment and end markets.
Contract Balances
As of
(in thousands)December 28, 2024September 28, 2024
Contract liabilities
$12,443 $18,646 
Our contract liabilities are primarily related to payments received in advance of satisfying performance obligations, and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.
Contract liabilities increased as a result of receiving new advanced payments from customers, partially offset by the recognition in revenue of $9.6 million that was included in contract liabilities as of September 28, 2024.
v3.25.0.1
EARNINGS PER SHARE
3 Months Ended
Dec. 28, 2024
Earnings Per Share [Abstract]  
EARNINGS PER SHARE 12. EARNINGS PER SHARE
Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.
The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands, except per share data)December 28, 2024December 30, 2023
 BasicDilutedBasicDiluted
NUMERATOR:    
Net income
$81,642 $81,642 $9,293 $9,293 
DENOMINATOR:    
Weighted average shares outstanding - Basic53,791 53,791 56,650 56,650 
Dilutive effect of Equity Plans421 373 
Weighted average shares outstanding - Diluted  54,212  57,023 
EPS:    
Net income per share - Basic
$1.52 $1.52 $0.16 $0.16 
Effect of dilutive shares (0.01) — 
Net income per share - Diluted
 $1.51  $0.16 
Anti-dilutive shares(1)
125
(1) Represents the Time-based RSUs, Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three months ended December 28, 2024 and December 30, 2023 as the effect would have been anti-dilutive.
v3.25.0.1
INCOME TAXES
3 Months Ended
Dec. 28, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES 13. INCOME TAXES
The following table reflects the provision for income taxes and the effective tax rate for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(dollar amounts in thousands)December 28, 2024December 30, 2023
Provision for income taxes$11,332 $2,277 
Effective tax rate12.2 %19.7 %
For the three months ended December 28, 2024, the increase in provision for income taxes and the decrease in the effective tax rate was primarily due to the reimbursement from Project W cancellation which was recorded as a discrete item in the quarter.
For the three months ended December 28, 2024, the effective tax rate is different than the U.S. federal statutory tax rate primarily due to earnings of foreign subsidiaries subject to tax at different rates than the U.S., tax incentives, tax credits, changes in valuation allowances, the impact of Global Intangible Low-Taxed Income, and the tax impact from the reimbursement of Project W cancellation.
v3.25.0.1
SEGMENT INFORMATION
3 Months Ended
Dec. 28, 2024
Segment Reporting [Abstract]  
SEGMENT INFORMATION 14. SEGMENT INFORMATION
Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and assess performance. The Company’s Chief Executive Officer is the CODM. The CODM does not review discrete asset information.
The Company has four reportable segments consisting of: (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). The four reportable segments are disclosed below:
Ball Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment.
Wedge Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of wedge and wedge-related bonding equipment.
Advanced Solutions: Reflects the results of the Company from the design, development, manufacture and sale of certain advanced display, die-attach and thermocompression systems and solutions.
APS: Reflects the results of the Company from the design, development, manufacture and sale of a variety of tools, spares and services for our equipment.
Any other operating segments that have not been aggregated within the reportable segments described above which do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly and die-attach systems and solutions. Results for the “All Others” category and other corporate expenses are included as a reconciling item between the Company’s reportable segments and its consolidated results of operations.
The following table reflects operating information by segment for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Net revenue:  
Ball Bonding Equipment$59,686 $86,270 
Wedge Bonding Equipment32,223 23,459 
Advanced Solutions28,178 11,324 
APS39,386 41,241 
All Others6,651 8,895 
              Net revenue166,124 171,189 
Income from operations:
  
Ball Bonding Equipment13,428 27,714 
Wedge Bonding Equipment6,703 4,294 
Advanced Solutions78,574 (13,435)
APS11,255 12,246 
All Others(3,212)(8,074)
Corporate Expenses(20,099)(21,052)
           Income from operations
$86,649 $1,693 
We have considered: (1) information that is regularly reviewed by our CODM in evaluating financial performance and how to allocate resources; and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served.
The following table reflects net revenue by end markets served for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
General Semiconductor$65,559 $70,948 
Automotive & Industrial 31,175 23,521 
LED 19,279 5,732 
Memory 10,725 29,747 
APS39,386 41,241 
Total revenue$166,124 $171,189 
The following table reflects capital expenditures, depreciation expense and amortization expense for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Capital expenditures:
Ball Bonding Equipment$$396 
Wedge Bonding Equipment35 14 
Advanced Solutions78 244 
APS384 425 
All Others148 141 
Corporate Expenses1,459 2,313 
$2,111 $3,533 
Depreciation expense:  
Ball Bonding Equipment$332 $321 
Wedge Bonding Equipment227 284 
Advanced Solutions235 3,047 
APS1,399 1,323 
All Others328 380 
Corporate Expenses1,246 1,283 
$3,767 $6,638 
Amortization expense:
Ball Bonding Equipment$— $— 
Wedge Bonding Equipment— — 
Advanced Solutions— — 
APS281 226 
All Others873 1,029 
Corporate Expenses92 92 
$1,246 $1,347 
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS
3 Months Ended
Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS 15. COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS
Warranty Expense
The Company’s equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future warranty costs, including product part replacement, freight charges and related labor costs expected to be incurred in correcting manufacturing defects during the warranty period.
The following table reflects the reserve for warranty activity for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Reserve for warranty, beginning of period$9,911 $10,457 
Provision for warranty2,529 2,936 
Utilization of reserve(3,014)(3,226)
Reserve for warranty, end of period$9,426 $10,167 
Other Commitments and Contingencies
The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of December 28, 2024:
  Payments due by fiscal year
(in thousands)Total20252026202720282029Thereafter
Inventory purchase obligation (1)
$137,052 $47,166 $89,886 $— $— $— $— 
(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.
From time to time, the Company is party to or the target of lawsuits, claims, investigations and proceedings, including for personal injury, intellectual property, commercial, contract, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a contingent loss liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. The Company expenses legal costs, including those expected to be incurred in connection with a loss contingency, as incurred.
Unfunded Capital Commitments
As of December 28, 2024, the Company also has an obligation to fund uncalled capital commitments of approximately $6.2 million, as and when required, in relation to its investment in a private equity fund.
Concentrations
The following table reflects significant customer concentrations as a percentage of net revenue for the three months ended December 28, 2024 and December 30, 2023:
Three months ended
December 28, 2024December 30, 2023
First Technology China Ltd.(1)
11.8 %*
Tianshui Huatian Technology Co., Ltd.10.9 %*
Matfron (Shanghai) Semiconductor Technology Co.,Ltd.
*10.6 %
* Represents less than 10% of total net revenue
(1) Distributor of the Company’s products
The following table reflects significant customer concentrations as a percentage of total accounts receivable as of December 28, 2024 and December 30, 2023:
 As of
December 28, 2024December 30, 2023
Tianshui Huatian Technology Co., Ltd.23.4 %*
Forehope Electronic (Ningbo) Co., Ltd.11.8 %10.7 %
* Represents less than 10% of total accounts receivable
v3.25.0.1
CESSATION OF BUSINESS
3 Months Ended
Dec. 28, 2024
Cessation Of Business [Abstract]  
CESSATION OF BUSINESS 16. CESSATION OF BUSINESS
Cancellation of Project
The Company was engaged by one of its customers (the "Customer") to support the Customer with the development and future mass production of certain technologies relating to advanced display (the "Project"), previously referred to as Project W. As previously disclosed in fiscal 2024, in connection with the Customer's strategic review of its business, the Customer informed the Company that it cancelled the Project.
On November 4, 2024, the Company and the Customer entered into a written agreement pursuant to which the Customer had agreed to reimburse the Company for certain costs and expenses that the Company incurred in connection with the Project. Pursuant to the agreement, the Customer agreed to pay $86.2 million to the Company. $15.1 million was included within "Net Revenue" for delivered products. The remaining $71.1 million was included in "Gain relating to cessation of business" in the Consolidated Condensed Statements of Operations, with the corresponding increase to the Accounts and other receivable in our Consolidated Condensed Balance Sheets.
Disposal of a subsidiary
On October 16, 2024, the Company, through one of its subsidiaries, Kulicke and Soffa Holland Holdings B.V., entered into a Share Sale and Purchase Agreement with Onto Innovation Europe B.V. ("Onto") for the sale of 100% of the common shares of Kulicke & Soffa Liteq B.V. ("K&S Liteq") and its related lithography business. The sale was completed on October 18, 2024. Accordingly, the Company has deconsolidated K&S Liteq in the Company’s unaudited condensed consolidated financial statements. The disposal of K&S Liteq did not have a material impact on our consolidated financial statements.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Pay vs Performance Disclosure    
Net income $ 81,642 $ 9,293
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 28, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Nelson Wong [Member]  
Trading Arrangements, by Individual  
Name Nelson Wong
Title Senior Vice President
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 2, 2024
Arrangement Duration 549 days
Aggregate Available 70,000
v3.25.0.1
BASIS OF PRESENTATION (Policies)
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidation
These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“K&S,” “we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.
The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 28, 2024 (the “2024 Annual Report”) filed with the Securities and Exchange Commission on November 14, 2024, which includes the Consolidated Balance Sheets as of September 28, 2024 and September 30, 2023, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended September 28, 2024. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.
Fiscal Year
Fiscal Year    
Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2025 quarters end on December 28, 2024, March 29, 2025, June 28, 2025 and October 4, 2025. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2024 quarters ended on December 30, 2023, March 30, 2024, June 29, 2024 and September 28, 2024.
Nature of business
Nature of Business
The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.
Use of Estimates
Use of Estimates
The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory and inventory valuation, carrying value and lives of fixed assets, goodwill and intangible assets, accrual for customer credit programs, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, accrual for employee termination benefits and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.
In light of macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of December 28, 2024. While there was no material impact from macroeconomic headwinds to our consolidated condensed financial statements as of and for the quarter ended December 28, 2024, these estimates may change, as new events occur and additional information is obtained, including factors related to these headwinds, that could materially impact our consolidated condensed financial statements in future reporting periods.
Significant Accounting Policies
Significant Accounting Policies
There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2024 Annual Report.
Recent accounting pronouncements
Recent Accounting Pronouncements
Disclosure Improvements
In October 2023, the Financial Accounting Standards Board (the "FASB") issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative. This ASU aligns the requirements in the FASB Accounting Standards Codification with the SEC’s regulations. The amendments in the ASU are expected to clarify or improve disclosure and presentation requirements over a variety of Codification Topics. They will also allow users to more easily compare entities subject to the SEC’s existing disclosures with those entities that were not previously subject to the requirements, and align the requirements in the Codification with the SEC’s regulations. This ASU will become effective for each amendment on the date on which the SEC removes the related disclosure from its regulations. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the Codification and not become effective for any entity. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Segment Reporting
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure, which aims to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the amendments in the ASU enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The purpose of the amendments is to enable investors to better understand an entity's overall performance and assess potential future cash flows. This ASU will be effective for the Company's fiscal year 2025, and interim periods within the fiscal years beginning after the Company’s fiscal year 2026. Early adoption is permitted. The Company will include the required Segment Reporting disclosures within the Notes to Financial Statements with the filing of its Annual Report on Form 10-K for the year ending on October 4, 2025.
Income Taxes
In December 2023, the FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvement to Income Tax Disclosures. The amendments in this update are intended to enhance the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. This ASU will be effective for the Company's fiscal year 2026. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03 Income Statement - Reporting Comprehensive Income -Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses. This ASU requires disclosure of certain expenses in the notes to the financial statements. This ASU will be effective for the Company's fiscal 2028 on a prospective basis, with retrospective application permitted. The Company is currently evaluating the impact the adoption of this standard will have on its consolidated financial statements.
v3.25.0.1
BALANCE SHEET COMPONENTS (Tables)
3 Months Ended
Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Components of significant balance sheet accounts
Components of significant balance sheet accounts as of December 28, 2024 and September 28, 2024 are as follows:
 As of
(in thousands)December 28, 2024September 28, 2024
Inventories, net:  
Raw materials and supplies $110,245 $113,119 
Work in process 43,655 43,023 
Finished goods 58,284 53,378 
 212,184 209,520 
Inventory reserves
(27,124)(31,784)
 $185,060 $177,736 
Property, plant and equipment, net (1):
  
Land$2,182 $2,182 
Buildings and building improvements27,801 23,951 
Leasehold improvements
39,064 44,682 
Data processing equipment and software
37,879 37,917 
Machinery, equipment, furniture and fixtures103,288 105,548 
Construction in progress
6,930 10,060 
 217,144 224,340 
Accumulated depreciation (154,677)(159,517)
 $62,467 $64,823 
Accrued expenses and other current liabilities:  
Accrued customer obligations (2)
$24,822 $31,014 
Wages and benefits
29,110 31,349 
Dividends payable10,987 10,794 
Commissions and professional fees 3,839 4,654 
Accrued leasehold renovations — 6,476 
Other8,315 6,515 
 $77,073 $90,802 
(1)Certain balances previously presented as Accumulated Impairment as of September 28, 2024 have been reclassified to conform to the current period presentation. These reclassifications have no impact to the consolidated financial statements in the fiscal period.
(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.
v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
3 Months Ended
Dec. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes the changes in the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 14 for further information) as of December 28, 2024 and September 28, 2024:
(in thousands)Wedge Bonding EquipmentAPSAll OthersTotal
Balance at September 28, 2024(1)
$18,280 $26,268 45,200 $89,748 
Other— (198)(1,139)$(1,337)
Balance at December 28, 2024$18,280 $26,070 44,061 $88,411 
(1) Cumulative goodwill impairment pertaining to the “All Others” category as of September 28, 2024 was $45.0 million.
Net intangible assets
The following table reflects net intangible assets as of December 28, 2024 and September 28, 2024: 
 
As of December 28, 2024
As of September 28, 2024
(dollar amounts in thousands)Average estimated
useful lives
(in years)
Gross Carrying AmountAccumulated AmortizationNet AmountGross Carrying AmountAccumulated AmortizationNet Amount
Developed technology
6.0 to 15.0
$80,364 $(60,801)$19,563 $83,401 $(61,575)$21,826 
Customer relationships
5.0 to 8.0
$36,554 $(34,912)$1,642 $37,625 $(35,916)$1,709 
Trade and brand name
7.0 to 8.0
$7,095 $(7,095)$— $7,272 $(7,272)$— 
Other intangible assets
1.0 to 8.0
$5,617 $(4,479)$1,138 $5,617 $(4,372)$1,245 
In-process research and developmentN.A$459 $— $459 $459 $— $459 
$130,089 $(107,287)$22,802 $134,374 $(109,135)$25,239 
Estimated annual amortization expense related to intangible assets
The following table reflects estimated annual amortization expense related to intangible assets as of December 28, 2024:
 As of
(in thousands)December 28, 2024
Remaining fiscal 2025
$3,705 
Fiscal 2026
4,940 
Fiscal 20274,665 
Fiscal 2028
4,244 
Fiscal 2029
3,255 
Thereafter1,993 
Total amortization expense$22,802 
v3.25.0.1
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Tables)
3 Months Ended
Dec. 28, 2024
Cash and Cash Equivalents [Abstract]  
Cash, cash equivalents, restricted cash and short-term investments
Cash, cash equivalents, and short-term investments consisted of the following as of December 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$27,050 $— $— $27,050 
Cash equivalents:
Mutual Funds (1)
214,247 — (3)214,244 
Time deposits (2)
37,031 — — 37,031 
Total cash and cash equivalents$278,328 $— $(3)$278,325 
Short-term investments:
Time deposits (2)
260,000 — — 260,000 
Total short-term investments$260,000 $— $— $260,000 
Total cash, cash equivalents and short-term investments$538,328 $— $(3)$538,325 
(1)Mutual funds held by the Company include Money Market Funds and Ultra-Short Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 28, 2024.
Cash, cash equivalents and short-term investments consisted of the following as of September 28, 2024:
(in thousands)Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Current assets:
Cash$26,800 $— $— $26,800 
Cash equivalents:
Mutual Funds (1)
157,590 89 — 157,679 
Time deposits (2)
42,668 — — 42,668 
Total cash and cash equivalents$227,058 $89 $— $227,147 
Short-term investments:
Time deposits (2)
350,000 — — 350,000 
Total short-term investments$350,000 $— $— $350,000 
Total cash, cash equivalents and short-term investments$577,058 $89 $— $577,147 
(1)Mutual funds held by the Company include Money Market Funds. The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.
(2)The fair value of all short-term investments approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three months ended December 30, 2023.
v3.25.0.1
EQUITY INVESTMENTS (Tables)
3 Months Ended
Dec. 28, 2024
Equity Method Investments [Abstract]  
Equity investments
Equity investments consisted of the following as of December 28, 2024 and September 28, 2024:
 As of
(in thousands)December 28, 2024September 28, 2024
Non-marketable equity securities$3,385 $3,143 
v3.25.0.1
DERIVATIVES FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Dec. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of December 28, 2024 and September 28, 2024 were as follows:
As of
December 28, 2024September 28, 2024
(in thousands)Notional Amount
Fair Value Liability
Derivatives(1)
Notional Amount
Fair Value Asset Derivatives(2)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)
$42,486 $(1,047)$46,234 $1,521 
Total derivatives$42,486 $(1,047)$46,234 $1,521 
(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.
(2)The fair value of derivative assets is measured using level 2 fair value inputs and is included in prepaid expenses and other current assets on our Consolidated Condensed Balance Sheets.
(3)Hedged amounts expected to be recognized to income within the next twelve months.
Derivative Instruments, Gain (Loss)
The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three months ended December 28, 2024 and December 30, 2023 were as follows:
Three months ended
(in thousands)December 28, 2024December 30, 2023
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss) / gain recognized in OCI, net of tax(1)
$(2,285)$1,255 
Net gain / (loss) reclassified from accumulated OCI into income, net of tax(2)
$283 $(215)
(1)Net change in the fair value of the effective portion classified in OCI.
(2)Effective portion classified as selling, general and administrative expense.
v3.25.0.1
LEASES (Tables)
3 Months Ended
Dec. 28, 2024
Leases [Abstract]  
Lease expense and components of lease expense
The following table shows the components of lease expense:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Operating lease expense (1)
$2,348 $2,857 
(1)Operating lease expense includes short-term lease expense and variable lease expenses, which is immaterial for the three months ended December 28, 2024 and December 30, 2023.
The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
 Operating cash outflows from operating leases$2,570 $2,422 
Weighted-average lease terms and discount rates
The following table shows the weighted-average lease terms and discount rates for operating leases:
 As of
December 28, 2024September 28, 2024
Operating leases:
Weighted-average remaining lease term (in years):
7.17.3
Weighted-average discount rate:7.1 %7.2 %
Future lease payments after ASC 842 adoption
Future lease payments, excluding short-term leases, as of December 28, 2024, are detailed as follows:
As of
(in thousands)December 28, 2024
Remaining fiscal 2025$7,552 
Fiscal 20267,654 
Fiscal 20275,516 
Fiscal 20284,860 
Fiscal 20294,788 
Thereafter17,688 
Total minimum lease payments$48,058 
Less: Interest$10,484 
Present value of lease obligations$37,574 
Less: Current portion$7,048 
Long-term portion of lease obligations$30,526 
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Tables)
3 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Accumulated other comprehensive income reflected on the Consolidated Balance Sheets
The following table reflects changes in accumulated other comprehensive income/(loss) by component as of December 28, 2024 and September 28, 2024: 
(in thousands)Cumulative Foreign Currency Translation AdjustmentPension Plan Adjustments
Gain/(Loss) on Derivative Instruments
Total
As of September 28, 2024
$(13,261)$(1,682)$1,521 $(13,422)
Other comprehensive income/(loss) before reclassifications
(7,923)118 (2,285)(10,090)
Amount reclassified out of accumulated other comprehensive income/(loss)
(815)— (283)(1,098)
Tax effects481 — — 481 
Other comprehensive income/(loss)
(8,257)118 (2,568)(10,707)
As of December 28, 2024
$(21,518)$(1,564)$(1,047)$(24,129)
Restricted stock and common stock granted
The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(shares in thousands)December 28, 2024December 30, 2023
Time-based RSUs563 499 
Relative TSR PSUs128 231 
Growth PSUs— 49 
Common stock
Equity-based compensation in shares698 786 
Equity-based compensation expense
The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Cost of sales$383 $359 
Selling, general and administrative 3,739 5,680 
Research and development2,019 1,818 
Total equity-based compensation expense$6,141 $7,857 
The following table reflects equity-based compensation expense, by type of award, for the three months ended December 28, 2024 and December 30, 2023:  
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Time-based RSUs$5,156 $4,543 
Relative TSR PSUs1,778 1,560 
Growth PSUs(1,108)1,439 
Common stock315 315 
Total equity-based compensation expense $6,141 $7,857 
v3.25.0.1
REVENUE AND CONTRACT BALANCES (Tables)
3 Months Ended
Dec. 28, 2024
Revenue from Contract with Customer [Abstract]  
Contract Assets and Liabilities
Contract Balances
As of
(in thousands)December 28, 2024September 28, 2024
Contract liabilities
$12,443 $18,646 
v3.25.0.1
EARNINGS PER SHARE (Tables)
3 Months Ended
Dec. 28, 2024
Earnings Per Share [Abstract]  
Reconciliation of shares used in the basic and diluted net income per share computation
The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands, except per share data)December 28, 2024December 30, 2023
 BasicDilutedBasicDiluted
NUMERATOR:    
Net income
$81,642 $81,642 $9,293 $9,293 
DENOMINATOR:    
Weighted average shares outstanding - Basic53,791 53,791 56,650 56,650 
Dilutive effect of Equity Plans421 373 
Weighted average shares outstanding - Diluted  54,212  57,023 
EPS:    
Net income per share - Basic
$1.52 $1.52 $0.16 $0.16 
Effect of dilutive shares (0.01) — 
Net income per share - Diluted
 $1.51  $0.16 
Anti-dilutive shares(1)
125
(1) Represents the Time-based RSUs, Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three months ended December 28, 2024 and December 30, 2023 as the effect would have been anti-dilutive.
v3.25.0.1
INCOME TAXES (Tables)
3 Months Ended
Dec. 28, 2024
Income Tax Disclosure [Abstract]  
Provision for income taxes and the effective tax rate
The following table reflects the provision for income taxes and the effective tax rate for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(dollar amounts in thousands)December 28, 2024December 30, 2023
Provision for income taxes$11,332 $2,277 
Effective tax rate12.2 %19.7 %
v3.25.0.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Dec. 28, 2024
Segment Reporting [Abstract]  
Operating information by segment
The following table reflects operating information by segment for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Net revenue:  
Ball Bonding Equipment$59,686 $86,270 
Wedge Bonding Equipment32,223 23,459 
Advanced Solutions28,178 11,324 
APS39,386 41,241 
All Others6,651 8,895 
              Net revenue166,124 171,189 
Income from operations:
  
Ball Bonding Equipment13,428 27,714 
Wedge Bonding Equipment6,703 4,294 
Advanced Solutions78,574 (13,435)
APS11,255 12,246 
All Others(3,212)(8,074)
Corporate Expenses(20,099)(21,052)
           Income from operations
$86,649 $1,693 
Schedule of net revenue by Capital Equipment end markets
The following table reflects net revenue by end markets served for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
General Semiconductor$65,559 $70,948 
Automotive & Industrial 31,175 23,521 
LED 19,279 5,732 
Memory 10,725 29,747 
APS39,386 41,241 
Total revenue$166,124 $171,189 
Capital expenditures, depreciation and amortization expense
The following table reflects capital expenditures, depreciation expense and amortization expense for the three months ended December 28, 2024 and December 30, 2023:
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Capital expenditures:
Ball Bonding Equipment$$396 
Wedge Bonding Equipment35 14 
Advanced Solutions78 244 
APS384 425 
All Others148 141 
Corporate Expenses1,459 2,313 
$2,111 $3,533 
Depreciation expense:  
Ball Bonding Equipment$332 $321 
Wedge Bonding Equipment227 284 
Advanced Solutions235 3,047 
APS1,399 1,323 
All Others328 380 
Corporate Expenses1,246 1,283 
$3,767 $6,638 
Amortization expense:
Ball Bonding Equipment$— $— 
Wedge Bonding Equipment— — 
Advanced Solutions— — 
APS281 226 
All Others873 1,029 
Corporate Expenses92 92 
$1,246 $1,347 
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Tables)
3 Months Ended
Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Reserve for product warranty activity
The following table reflects the reserve for warranty activity for the three months ended December 28, 2024 and December 30, 2023: 
 Three months ended
(in thousands)December 28, 2024December 30, 2023
Reserve for warranty, beginning of period$9,911 $10,457 
Provision for warranty2,529 2,936 
Utilization of reserve(3,014)(3,226)
Reserve for warranty, end of period$9,426 $10,167 
Obligations not reflected on the Consolidated Balance Sheet
The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of December 28, 2024:
  Payments due by fiscal year
(in thousands)Total20252026202720282029Thereafter
Inventory purchase obligation (1)
$137,052 $47,166 $89,886 $— $— $— $— 
(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.
Schedule of Revenue by Major Customers by Reporting Segments
The following table reflects significant customer concentrations as a percentage of net revenue for the three months ended December 28, 2024 and December 30, 2023:
Three months ended
December 28, 2024December 30, 2023
First Technology China Ltd.(1)
11.8 %*
Tianshui Huatian Technology Co., Ltd.10.9 %*
Matfron (Shanghai) Semiconductor Technology Co.,Ltd.
*10.6 %
* Represents less than 10% of total net revenue
(1) Distributor of the Company’s products
Significant customer concentrations as a percentage of total accounts receivable
The following table reflects significant customer concentrations as a percentage of total accounts receivable as of December 28, 2024 and December 30, 2023:
 As of
December 28, 2024December 30, 2023
Tianshui Huatian Technology Co., Ltd.23.4 %*
Forehope Electronic (Ningbo) Co., Ltd.11.8 %10.7 %
* Represents less than 10% of total accounts receivable
v3.25.0.1
BALANCE SHEET COMPONENTS (Components of significant balance sheet accounts) (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Short-term investments $ 260,000 $ 350,000
Inventories, net:    
Raw materials and supplies 110,245 113,119
Work in process 43,655 43,023
Finished goods 58,284 53,378
Inventory, gross 212,184 209,520
Inventory reserves (27,124) (31,784)
Inventories, net 185,060 177,736
Property, plant and equipment, net    
Land 2,182 2,182
Buildings and building improvements 27,801 23,951
Leasehold improvements 39,064 44,682
Data processing equipment and software 37,879 37,917
Machinery, equipment, furniture and fixtures 103,288 105,548
Construction in progress 6,930 10,060
Property, plant and equipment, gross 217,144 224,340
Accumulated depreciation (154,677) (159,517)
Property, plant and equipment, net 62,467 64,823
Accrued expenses and other current liabilities:    
Accrued customer obligations 24,822 31,014
Wages and benefits 29,110 31,349
Dividends payable 10,987 10,794
Commissions and professional fees 3,839 4,654
Accrued leasehold renovations 0 6,476
Other 8,315 6,515
Accrued expenses and other current liabilities $ 77,073 $ 90,802
v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS (Goodwill by Reportable Segment) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Goodwill [Roll Forward]    
Beginning Balance $ 89,748  
Other (1,337)  
Ending Balance 88,411  
Wedge Bonding Equipment    
Goodwill [Roll Forward]    
Beginning Balance 18,280  
Other 0  
Ending Balance 18,280  
APS    
Goodwill [Roll Forward]    
Beginning Balance 26,268  
Other (198)  
Ending Balance 26,070  
All Others    
Goodwill [Roll Forward]    
Beginning Balance 45,200  
Other (1,139)  
Ending Balance $ 44,061  
Goodwill, cumulative impairment   $ 45,000
v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS (Net intangible assets) (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount $ 130,089 $ 134,374
Accumulated Amortization (107,287) (109,135)
Net Amount 22,802 25,239
In-process research and development    
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount 459 459
Accumulated Amortization 0 0
Net Amount 459 459
Developed technology    
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount 80,364 83,401
Accumulated Amortization (60,801) (61,575)
Net Amount $ 19,563 21,826
Developed technology | Minimum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 6 years  
Developed technology | Maximum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 15 years  
Customer relationships    
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount $ 36,554 37,625
Accumulated Amortization (34,912) (35,916)
Net Amount $ 1,642 1,709
Customer relationships | Minimum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 5 years  
Customer relationships | Maximum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 8 years  
Trade and brand name    
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount $ 7,095 7,272
Accumulated Amortization (7,095) (7,272)
Net Amount $ 0 0
Trade and brand name | Minimum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 7 years  
Trade and brand name | Maximum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 8 years  
Other intangible assets    
Schedule Of Intangible Assets [Line Items]    
Gross Carrying Amount $ 5,617 5,617
Accumulated Amortization (4,479) (4,372)
Net Amount $ 1,138 $ 1,245
Other intangible assets | Minimum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 1 year  
Other intangible assets | Maximum    
Schedule Of Intangible Assets [Line Items]    
Average estimated useful lives (in years) 8 years  
v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS (Estimated annual amortization expense) (Details)
$ in Thousands
Dec. 28, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remaining fiscal 2025 $ 3,705
Fiscal 2026 4,940
Fiscal 2027 4,665
Fiscal 2028 4,244
Fiscal 2029 3,255
Thereafter 1,993
Total amortization expense $ 22,802
v3.25.0.1
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]    
Cash, Amortized Cost $ 27,050 $ 26,800
Cash, Unrealized Gains 0 0
Cash, Unrealized Losses 0 0
Cash, Estimated Fair Value 27,050 26,800
Cash and Cash Equivalents, Amortized Cost 278,328 227,058
Cash and Cash Equivalents, Unrealized Gain 0 89
Cash and Cash Equivalents, Unrealized Loss (3) 0
Cash and Cash Equivalents, Estimated Fair Value 278,325 227,147
Short-term investments, Amortized Cost 260,000 350,000
Short-term Investments, Unrealized Gain 0 0
Short-term Investments, Unrealized Loss 0 0
Short-term Investments, Estimated Fair Value 260,000 350,000
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Amortized Cost 538,328 577,058
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Unrealized Gain 0 89
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Unrealized Loss (3) 0
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Estimated Fair Value 538,325 577,147
Mutual Funds    
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]    
Cash Equivalents, Amortized Cost 214,247 157,590
Cash Equivalents, Unrealized Gain 0 89
Cash Equivalents, Unrealized Loss (3) 0
Cash Equivalents, Estimated Fair Value 214,244 157,679
Time deposits    
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]    
Cash Equivalents, Amortized Cost 37,031 42,668
Cash Equivalents, Unrealized Gain 0 0
Cash Equivalents, Unrealized Loss 0 0
Cash Equivalents, Estimated Fair Value 37,031 42,668
Short-term investments, Amortized Cost 260,000 350,000
Short-term Investments, Unrealized Gain 0 0
Short-term Investments, Unrealized Loss 0 0
Short-term Investments, Estimated Fair Value $ 260,000 $ 350,000
v3.25.0.1
EQUITY INVESTMENTS (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Equity Method Investments [Abstract]    
Non-marketable equity securities $ 3,385 $ 3,143
Equity securities funded 3,800  
Unrealized fair value loss $ 400  
v3.25.0.1
DERIVATIVES FINANCIAL INSTRUMENTS - Additional information (Details)
3 Months Ended
Dec. 28, 2024
Foreign exchange forward contracts | Derivatives designated as hedging instruments:  
Derivative Instruments, Gain (Loss) [Line Items]  
Derivative, term of contract 12 months
v3.25.0.1
DERIVATIVES FINANCIAL INSTRUMENTS (Fair value of derivative instruments) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Sep. 28, 2024
Derivatives, Fair Value [Line Items]    
Notional Amount $ 42,486 $ 46,234
Fair value liability, derivates $ (1,047)  
Fair value asset, derivatives   1,521
Gain (loss) reclassification, estimate of time to transfer 12 months  
Derivatives designated as hedging instruments: | Foreign exchange forward contracts    
Derivatives, Fair Value [Line Items]    
Notional Amount $ 42,486 46,234
Fair value liability, derivates $ (1,047)  
Fair value asset, derivatives   $ 1,521
v3.25.0.1
DERIVATIVES FINANCIAL INSTRUMENTS (Gain (loss) of derivative instruments) (Details) - Gain/(Loss) on Derivative Instruments - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]    
Unrealized (loss) / gain on derivative instruments, net of tax $ (2,285) $ 1,255
Reclassification adjustment for loss / (gain) on derivative instruments recognized, net of tax $ 283 $ (215)
v3.25.0.1
LEASES - Narrative (Details)
3 Months Ended
Dec. 28, 2024
extend_options
Lessee, Lease, Description [Line Items]  
Options to extend 0
Minimum  
Lessee, Lease, Description [Line Items]  
Operating lease, term of contract 1 year
Maximum  
Lessee, Lease, Description [Line Items]  
Operating lease, term of contract 20 years
v3.25.0.1
LEASES - Lease Expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Lease, Cost [Abstract]    
Operating lease expense $ 2,348 $ 2,857
Cash paid for amounts included in the measurement of lease liabilities:    
Operating cash outflows from operating leases $ 2,570 $ 2,422
v3.25.0.1
LEASES - Lease Terms and Discount Rates (Details)
Dec. 28, 2024
Sep. 28, 2024
Leases [Abstract]    
Weighted-average remaining lease term (in years): 7 years 1 month 6 days 7 years 3 months 18 days
Weighted-average discount rate: 7.10% 7.20%
v3.25.0.1
LEASES - Future Lease Payments After Adoption ASC 842 (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
Remaining fiscal 2025 $ 7,552  
Fiscal 2026 7,654  
Fiscal 2027 5,516  
Fiscal 2028 4,860  
Fiscal 2029 4,788  
Thereafter 17,688  
Total minimum lease payments 48,058  
Less: Interest 10,484  
Present value of lease obligations 37,574  
Less: Current portion 7,048 $ 7,718
Long-term portion of lease obligations $ 30,526 $ 33,245
v3.25.0.1
DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Details) - USD ($)
3 Months Ended
Dec. 28, 2024
Feb. 15, 2019
Nov. 22, 2013
Citibank      
Capital Leased Assets [Line Items]      
Capacity under credit facility     $ 5,000,000.0
Outstanding amounts under credit facility $ 4,700,000    
Facility agreements | MUFG Bank, Ltd., Singapore Branch      
Capital Leased Assets [Line Items]      
Capacity under credit facility   $ 150,000,000.0  
Outstanding amounts under credit facility $ 0    
Debt instrument, basis spread on variable rate 1.50%    
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Nov. 13, 2024
Mar. 03, 2022
Jul. 03, 2020
Jan. 31, 2019
Jul. 10, 2018
Aug. 15, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock repurchase program, authorized amount       $ 800,000 $ 400,000 $ 300,000 $ 200,000  
Value of shares acquired $ 36,879 $ 26,840            
Cash dividends declared (in dollars per share) $ 0.205 $ 0.20            
Increase of cash dividend (in dollars per share) $ 0.005              
Payments of ordinary dividends $ 10,794 $ 10,710            
Relative TSR calculation period 90 days              
Relative TSR Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total shareholder return award performance measurement period 3 years              
Revenue Growth Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total shareholder return award performance measurement period 3 years              
Time-based Restricted Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total shareholder return award performance measurement period 3 years              
Omnibus Incentive Plan                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Shares available for grant (in shares) 1,100,000              
the Program                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock repurchase program, authorized amount               $ 100,000
Shares repurchased in period (shares) 657,000.0              
Value of shares acquired $ 30,300              
New Program                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Stock repurchase program, authorized amount     $ 300,000          
Shares repurchased in period (shares) 136,000.0              
Value of shares acquired $ 6,600              
Remaining repurchase authorized amount $ 293,400              
Minimum | Relative TSR Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting percentage 0.00%              
Minimum | Revenue Growth Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting percentage 0.00%              
Maximum | Relative TSR Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting percentage 200.00%              
Maximum | Revenue Growth Performance Share Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Vesting percentage 200.00%              
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Accumulated other comprehensive income) (Details)
$ in Thousands
3 Months Ended
Dec. 28, 2024
USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Balances, beginning of period $ (13,422)
Other comprehensive income/(loss) before reclassifications (10,090)
Amount reclassified out of accumulated other comprehensive income/(loss) (1,098)
Tax effects 481
Other comprehensive income/(loss) (10,707)
Balances, end of period (24,129)
Cumulative Foreign Currency Translation Adjustment  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Balances, beginning of period (13,261)
Other comprehensive income/(loss) before reclassifications (7,923)
Amount reclassified out of accumulated other comprehensive income/(loss) (815)
Tax effects 481
Other comprehensive income/(loss) (8,257)
Balances, end of period (21,518)
Pension Plan Adjustments  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Balances, beginning of period (1,682)
Other comprehensive income/(loss) before reclassifications 118
Amount reclassified out of accumulated other comprehensive income/(loss) 0
Tax effects 0
Other comprehensive income/(loss) 118
Balances, end of period (1,564)
Gain/(Loss) on Derivative Instruments  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Balances, beginning of period 1,521
Other comprehensive income/(loss) before reclassifications (2,285)
Amount reclassified out of accumulated other comprehensive income/(loss) (283)
Tax effects 0
Other comprehensive income/(loss) (2,568)
Balances, end of period $ (1,047)
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Restricted stock and common stock granted) (Details) - shares
shares in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity-based compensation in shares 698 786
Time-based RSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity-based compensation in shares 563 499
Relative TSR PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity-based compensation in shares 128 231
Growth PSUs    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity-based compensation in shares 0 49
Common Stock    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Equity-based compensation in shares 7 7
v3.25.0.1
SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Total equity-based compensation expense) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense $ 6,141 $ 7,857
Time-based RSUs    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense 5,156 4,543
Relative TSR PSUs    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense 1,778 1,560
Growth PSUs    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense (1,108) 1,439
Common Stock    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense 315 315
Cost of sales    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense 383 359
Selling, general and administrative    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense 3,739 5,680
Research and development    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Total equity-based compensation expense $ 2,019 $ 1,818
v3.25.0.1
REVENUE AND CONTRACT BALANCES (Details) - USD ($)
$ in Thousands
Dec. 28, 2024
Sep. 28, 2024
Revenue from Contract with Customer [Abstract]    
Contract liabilities $ 12,443 $ 18,646
v3.25.0.1
REVENUE AND CONTRACT BALANCES - Narrative (Details)
$ in Millions
3 Months Ended
Dec. 28, 2024
USD ($)
Revenue from Contract with Customer [Abstract]  
Contract with customer, liability, revenue recognized $ 9.6
v3.25.0.1
EARNINGS PER SHARE (Reconciliation of the shares used in the basic and diluted net income per share computation) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
NUMERATOR:    
Net income $ 81,642 $ 9,293
DENOMINATOR:    
Weighted average shares outstanding - Basic (in shares) 53,791,000 56,650,000
Dilutive effect of Equity Plans (in shares) 421,000 373,000
Weighted average shares outstanding - Diluted (in shares) 54,212,000 57,023,000
EPS:    
Net income per share - Basic (in dollars per share) $ 1.52 $ 0.16
Effect of dilutive shares (in dollars per share) 0.01 0
Net income per share - Diluted (in dollars per share) $ 1.51 $ 0.16
Anti-dilutive shares (in shares) 1,000 25,000
v3.25.0.1
INCOME TAXES (Provision for income taxes and the effective tax rate) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Income Tax Disclosure [Abstract]    
Provision for income taxes $ 11,332 $ 2,277
Effective tax rate 12.20% 19.70%
v3.25.0.1
SEGMENT INFORMATION (Narrative) (Details)
3 Months Ended
Dec. 28, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 4
v3.25.0.1
SEGMENT INFORMATION (Operating information by segment) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Net revenue:    
Net revenue $ 166,124 $ 171,189
Income from operations:    
Income from operations 86,649 1,693
Ball Bonding Equipment    
Net revenue:    
Net revenue 59,686 86,270
Income from operations:    
Income from operations 13,428 27,714
Wedge Bonding Equipment    
Net revenue:    
Net revenue 32,223 23,459
Income from operations:    
Income from operations 6,703 4,294
Advanced Solutions    
Net revenue:    
Net revenue 28,178 11,324
Income from operations:    
Income from operations 78,574 (13,435)
APS    
Net revenue:    
Net revenue 39,386 41,241
Income from operations:    
Income from operations 11,255 12,246
All Others    
Net revenue:    
Net revenue 6,651 8,895
Income from operations:    
Income from operations (3,212) (8,074)
Corporate Expenses    
Income from operations:    
Income from operations $ (20,099) $ (21,052)
v3.25.0.1
SEGMENT INFORMATION (Schedule of net revenue by Capital Equipment end markets (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue $ 166,124 $ 171,189
Wedge Bonding Equipment | General Semiconductor    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue 65,559 70,948
Wedge Bonding Equipment | Automotive & Industrial    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue 31,175 23,521
Wedge Bonding Equipment | LED    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue 19,279 5,732
Wedge Bonding Equipment | Memory    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue 10,725 29,747
APS    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Total revenue $ 39,386 $ 41,241
v3.25.0.1
SEGMENT INFORMATION (Capital expenditures, depreciation and amortization expense by segment) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: $ 2,111 $ 3,533
Depreciation and amortization expense:    
Depreciation expense: 3,767 6,638
Amortization expense: 1,246 1,347
Ball Bonding Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 7 396
Depreciation and amortization expense:    
Depreciation expense: 332 321
Amortization expense: 0 0
Wedge Bonding Equipment    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 35 14
Depreciation and amortization expense:    
Depreciation expense: 227 284
Amortization expense: 0 0
Advanced Solutions    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 78 244
Depreciation and amortization expense:    
Depreciation expense: 235 3,047
Amortization expense: 0 0
APS    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 384 425
Depreciation and amortization expense:    
Depreciation expense: 1,399 1,323
Amortization expense: 281 226
All Others    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 148 141
Depreciation and amortization expense:    
Depreciation expense: 328 380
Amortization expense: 873 1,029
Corporate Expenses    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Capital expenditures: 1,459 2,313
Depreciation and amortization expense:    
Depreciation expense: 1,246 1,283
Amortization expense: $ 92 $ 92
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Reserve for product warranty activity) (Details) - USD ($)
$ in Thousands
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]    
Reserve for warranty, beginning of period $ 9,911 $ 10,457
Provision for warranty 2,529 2,936
Utilization of reserve (3,014) (3,226)
Reserve for warranty, end of period $ 9,426 $ 10,167
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Obligations not reflected on the Consolidated Balance Sheet) (Details)
$ in Thousands
Dec. 28, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Total $ 137,052
2025 47,166
2026 89,886
2027 0
2028 0
2029 0
Thereafter $ 0
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of net revenue) (Details) - Revenue Benchmark - Customer Concentration Risk
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Tianshui Huatian Technology Co., Ltd.    
Concentration Risk [Line Items]    
Customer concentrations risk percentage 10.90%  
First Technology China Ltd.    
Concentration Risk [Line Items]    
Customer concentrations risk percentage 11.80%  
Matfron (Shanghai) Semiconductor Technology Co.,Ltd.    
Concentration Risk [Line Items]    
Customer concentrations risk percentage   10.60%
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of total accounts receivable) (Details) - Accounts Receivable - Customer Concentration Risk
3 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Forehope Electronic (Ningbo) Co., Ltd.    
Concentration Risk [Line Items]    
Customer concentrations risk percentage 11.80% 10.70%
Tianshui Huatian Technology Co., Ltd.    
Concentration Risk [Line Items]    
Customer concentrations risk percentage 23.40%  
v3.25.0.1
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - Narrative (Details)
$ in Millions
3 Months Ended
Dec. 28, 2024
USD ($)
Other Commitments [Line Items]  
Period of warranty for manufacturing defects 1 year
Unfunded capital commitments  
Other Commitments [Line Items]  
Other commitment $ 6.2
v3.25.0.1
CESSATION OF BUSINESS (Details) - USD ($)
$ in Thousands
3 Months Ended
Nov. 04, 2024
Oct. 16, 2024
Dec. 28, 2024
Dec. 30, 2023
Subsidiary or Equity Method Investee [Line Items]        
Total revenue     $ 166,124 $ 171,189
Gain on contract termination     $ 75,987 $ 0
Project W        
Subsidiary or Equity Method Investee [Line Items]        
Loss contingency, receivable $ 86,200      
Total revenue 15,100      
Gain on contract termination $ 71,100      
Kulicke & Soffa Liteq B.V.        
Subsidiary or Equity Method Investee [Line Items]        
Sale of stock, percentage of ownership before transaction   100.00%    

Kulicke and Soffa Indust... (NASDAQ:KLIC)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Kulicke and Soffa Indust....
Kulicke and Soffa Indust... (NASDAQ:KLIC)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Kulicke and Soffa Indust....